Country	Age	Sex	n	denominator_unconditional	demoninator_conditional	Population	Step	WB
Kenya	15-29	Women	7	937	937	general	prevalence	LM
Kenya	30-44	Women	25	989	989	general	prevalence	LM
Kenya	45-59	Women	31	520	520	general	prevalence	LM
Kenya	60-79	Women	22	255	255	general	prevalence	LM
Kenya	15-29	Women	2	7	7	general	tested	LM
Kenya	30-44	Women	9	25	25	general	tested	LM
Kenya	45-59	Women	19	31	31	general	tested	LM
Kenya	60-79	Women	14	22	22	general	tested	LM
Kenya	15-29	Women	0	7	2	general	diagnosed	LM
Kenya	30-44	Women	7	25	9	general	diagnosed	LM
Kenya	45-59	Women	15	31	19	general	diagnosed	LM
Kenya	60-79	Women	11	22	14	general	diagnosed	LM
Kenya	15-29	Women	0	7	0	general	treated	LM
Kenya	30-44	Women	7	25	7	general	treated	LM
Kenya	45-59	Women	15	31	15	general	treated	LM
Kenya	60-79	Women	11	22	11	general	treated	LM
Kenya	15-29	Women	0	7	0	general	controlled	LM
Kenya	30-44	Women	4	25	7	general	controlled	LM
Kenya	45-59	Women	10	31	15	general	controlled	LM
Kenya	60-79	Women	7	22	11	general	controlled	LM
Kenya	all ages	Women	85	2701	2701	general	prevalence	LM
Kenya	all ages	Women	44	2701	85	general	tested	LM
Kenya	all ages	Women	33	2701	44	general	diagnosed	LM
Kenya	all ages	Women	33	2701	33	general	treated	LM
Kenya	all ages	Women	21	2701	33	general	controlled	LM
Kenya	15-29	Men	4	561	561	general	prevalence	LM
Kenya	30-44	Men	13	724	724	general	prevalence	LM
Kenya	45-59	Men	12	355	355	general	prevalence	LM
Kenya	60-79	Men	5	159	159	general	prevalence	LM
Kenya	15-29	Men	2	4	4	general	tested	LM
Kenya	30-44	Men	3	13	13	general	tested	LM
Kenya	45-59	Men	6	12	12	general	tested	LM
Kenya	60-79	Men	5	5	5	general	tested	LM
Kenya	15-29	Men	1	4	2	general	diagnosed	LM
Kenya	30-44	Men	2	13	3	general	diagnosed	LM
Kenya	45-59	Men	3	12	6	general	diagnosed	LM
Kenya	60-79	Men	3	5	5	general	diagnosed	LM
Kenya	15-29	Men	1	4	1	general	treated	LM
Kenya	30-44	Men	2	13	2	general	treated	LM
Kenya	45-59	Men	3	12	3	general	treated	LM
Kenya	60-79	Men	3	5	3	general	treated	LM
Kenya	15-29	Men	0	4	1	general	controlled	LM
Kenya	30-44	Men	1	13	2	general	controlled	LM
Kenya	45-59	Men	0	12	3	general	controlled	LM
Kenya	60-79	Men	2	5	3	general	controlled	LM
Kenya	all ages	Men	34	1799	1799	general	prevalence	LM
Kenya	all ages	Men	16	1799	34	general	tested	LM
Kenya	all ages	Men	9	1799	16	general	diagnosed	LM
Kenya	all ages	Men	9	1799	9	general	treated	LM
Kenya	all ages	Men	3	1799	9	general	controlled	LM
Armenia	15-29	Women	3	317	317	general	prevalence	LM
Armenia	30-44	Women	9	470	470	general	prevalence	LM
Armenia	45-59	Women	37	519	519	general	prevalence	LM
Armenia	60-79	Women	54	307	307	general	prevalence	LM
Armenia	15-29	Women	2	3	3	general	tested	LM
Armenia	30-44	Women	6	9	9	general	tested	LM
Armenia	45-59	Women	20	37	37	general	tested	LM
Armenia	60-79	Women	43	54	54	general	tested	LM
Armenia	15-29	Women	1	3	2	general	diagnosed	LM
Armenia	30-44	Women	2	9	6	general	diagnosed	LM
Armenia	45-59	Women	26	37	20	general	diagnosed	LM
Armenia	60-79	Women	38	54	43	general	diagnosed	LM
Armenia	15-29	Women	0	3	1	general	treated	LM
Armenia	30-44	Women	2	9	2	general	treated	LM
Armenia	45-59	Women	23	37	26	general	treated	LM
Armenia	60-79	Women	36	54	38	general	treated	LM
Armenia	15-29	Women	0	3	0	general	controlled	LM
Armenia	30-44	Women	1	9	2	general	controlled	LM
Armenia	45-59	Women	10	37	23	general	controlled	LM
Armenia	60-79	Women	19	54	36	general	controlled	LM
Armenia	all ages	Women	103	1613	1613	general	prevalence	LM
Armenia	all ages	Women	81	1613	103	general	tested	LM
Armenia	all ages	Women	67	1613	81	general	diagnosed	LM
Armenia	all ages	Women	61	1613	67	general	treated	LM
Armenia	all ages	Women	30	1613	61	general	controlled	LM
Armenia	15-29	Men	7	200	200	general	prevalence	LM
Armenia	30-44	Men	9	177	177	general	prevalence	LM
Armenia	45-59	Men	19	220	220	general	prevalence	LM
Armenia	60-79	Men	15	139	139	general	prevalence	LM
Armenia	15-29	Men	2	7	7	general	tested	LM
Armenia	30-44	Men	4	9	9	general	tested	LM
Armenia	45-59	Men	18	19	19	general	tested	LM
Armenia	60-79	Men	8	15	15	general	tested	LM
Armenia	15-29	Men	2	7	2	general	diagnosed	LM
Armenia	30-44	Men	1	9	4	general	diagnosed	LM
Armenia	45-59	Men	13	19	18	general	diagnosed	LM
Armenia	60-79	Men	8	15	8	general	diagnosed	LM
Armenia	15-29	Men	2	7	2	general	treated	LM
Armenia	30-44	Men	0	9	1	general	treated	LM
Armenia	45-59	Men	13	19	13	general	treated	LM
Armenia	60-79	Men	8	15	8	general	treated	LM
Armenia	15-29	Men	1	7	2	general	controlled	LM
Armenia	30-44	Men	0	9	0	general	controlled	LM
Armenia	45-59	Men	8	19	13	general	controlled	LM
Armenia	60-79	Men	6	15	8	general	controlled	LM
Armenia	all ages	Men	50	736	736	general	prevalence	LM
Armenia	all ages	Men	32	736	50	general	tested	LM
Armenia	all ages	Men	24	736	32	general	diagnosed	LM
Armenia	all ages	Men	23	736	24	general	treated	LM
Armenia	all ages	Men	15	736	23	general	controlled	LM
Azerbaijan	15-29	Women	7	267	267	general	prevalence	UM
Azerbaijan	30-44	Women	28	473	473	general	prevalence	UM
Azerbaijan	45-59	Women	83	677	677	general	prevalence	UM
Azerbaijan	60-79	Women	66	248	248	general	prevalence	UM
Azerbaijan	15-29	Women	3	7	7	general	tested	UM
Azerbaijan	30-44	Women	20	28	28	general	tested	UM
Azerbaijan	45-59	Women	68	83	83	general	tested	UM
Azerbaijan	60-79	Women	58	66	66	general	tested	UM
Azerbaijan	15-29	Women	2	7	3	general	diagnosed	UM
Azerbaijan	30-44	Women	12	28	20	general	diagnosed	UM
Azerbaijan	45-59	Women	57	83	68	general	diagnosed	UM
Azerbaijan	60-79	Women	51	66	58	general	diagnosed	UM
Azerbaijan	15-29	Women	2	7	2	general	treated	UM
Azerbaijan	30-44	Women	10	28	12	general	treated	UM
Azerbaijan	45-59	Women	56	83	57	general	treated	UM
Azerbaijan	60-79	Women	50	66	51	general	treated	UM
Azerbaijan	15-29	Women	0	7	2	general	controlled	UM
Azerbaijan	30-44	Women	4	28	10	general	controlled	UM
Azerbaijan	45-59	Women	29	83	56	general	controlled	UM
Azerbaijan	60-79	Women	36	66	50	general	controlled	UM
Azerbaijan	all ages	Women	184	1665	1665	general	prevalence	UM
Azerbaijan	all ages	Women	149	1665	184	general	tested	UM
Azerbaijan	all ages	Women	122	1665	149	general	diagnosed	UM
Azerbaijan	all ages	Women	118	1665	122	general	treated	UM
Azerbaijan	all ages	Women	69	1665	118	general	controlled	UM
Azerbaijan	15-29	Men	4	213	213	general	prevalence	UM
Azerbaijan	30-44	Men	9	312	312	general	prevalence	UM
Azerbaijan	45-59	Men	47	398	398	general	prevalence	UM
Azerbaijan	60-79	Men	38	213	213	general	prevalence	UM
Azerbaijan	15-29	Men	0	4	4	general	tested	UM
Azerbaijan	30-44	Men	2	9	9	general	tested	UM
Azerbaijan	45-59	Men	36	47	47	general	tested	UM
Azerbaijan	60-79	Men	32	38	38	general	tested	UM
Azerbaijan	15-29	Men	0	4	0	general	diagnosed	UM
Azerbaijan	30-44	Men	2	9	2	general	diagnosed	UM
Azerbaijan	45-59	Men	28	47	36	general	diagnosed	UM
Azerbaijan	60-79	Men	27	38	32	general	diagnosed	UM
Azerbaijan	15-29	Men	0	4	0	general	treated	UM
Azerbaijan	30-44	Men	1	9	2	general	treated	UM
Azerbaijan	45-59	Men	26	47	28	general	treated	UM
Azerbaijan	60-79	Men	26	38	27	general	treated	UM
Azerbaijan	15-29	Men	0	4	0	general	controlled	UM
Azerbaijan	30-44	Men	0	9	1	general	controlled	UM
Azerbaijan	45-59	Men	16	47	26	general	controlled	UM
Azerbaijan	60-79	Men	16	38	26	general	controlled	UM
Azerbaijan	all ages	Men	98	1136	1136	general	prevalence	UM
Azerbaijan	all ages	Men	70	1136	98	general	tested	UM
Azerbaijan	all ages	Men	57	1136	70	general	diagnosed	UM
Azerbaijan	all ages	Men	53	1136	57	general	treated	UM
Azerbaijan	all ages	Men	32	1136	53	general	controlled	UM
Afghanistan 	15-29	Women	122	786	786	general	prevalence	L
Afghanistan 	30-44	Women	123	632	632	general	prevalence	L
Afghanistan 	45-59	Women	101	385	385	general	prevalence	L
Afghanistan 	60-79	Women	41	113	113	general	prevalence	L
Afghanistan 	15-29	Women	16	122	122	general	tested	L
Afghanistan 	30-44	Women	40	123	123	general	tested	L
Afghanistan 	45-59	Women	45	101	101	general	tested	L
Afghanistan 	60-79	Women	17	41	41	general	tested	L
Afghanistan 	15-29	Women	14	122	16	general	diagnosed	L
Afghanistan 	30-44	Women	20	123	40	general	diagnosed	L
Afghanistan 	45-59	Women	37	101	45	general	diagnosed	L
Afghanistan 	60-79	Women	13	41	17	general	diagnosed	L
Afghanistan 	15-29	Women	14	122	14	general	treated	L
Afghanistan 	30-44	Women	20	123	20	general	treated	L
Afghanistan 	45-59	Women	35	101	37	general	treated	L
Afghanistan 	60-79	Women	13	41	13	general	treated	L
Afghanistan 	15-29	Women	3	122	14	general	controlled	L
Afghanistan 	30-44	Women	9	123	20	general	controlled	L
Afghanistan 	45-59	Women	13	101	35	general	controlled	L
Afghanistan 	60-79	Women	2	41	13	general	controlled	L
Afghanistan 	all ages	Women	386	1916	1916	general	prevalence	L
Afghanistan 	all ages	Women	119	1916	386	general	tested	L
Afghanistan 	all ages	Women	85	1916	119	general	diagnosed	L
Afghanistan 	all ages	Women	83	1916	85	general	treated	L
Afghanistan 	all ages	Women	27	1916	83	general	controlled	L
Afghanistan 	15-29	Men	91	712	712	general	prevalence	L
Afghanistan 	30-44	Men	68	544	544	general	prevalence	L
Afghanistan 	45-59	Men	91	447	447	general	prevalence	L
Afghanistan 	60-79	Men	72	305	305	general	prevalence	L
Afghanistan 	15-29	Men	20	91	91	general	tested	L
Afghanistan 	30-44	Men	28	68	68	general	tested	L
Afghanistan 	45-59	Men	49	91	91	general	tested	L
Afghanistan 	60-79	Men	38	72	72	general	tested	L
Afghanistan 	15-29	Men	13	91	20	general	diagnosed	L
Afghanistan 	30-44	Men	23	68	28	general	diagnosed	L
Afghanistan 	45-59	Men	35	91	49	general	diagnosed	L
Afghanistan 	60-79	Men	30	72	38	general	diagnosed	L
Afghanistan 	15-29	Men	12	91	13	general	treated	L
Afghanistan 	30-44	Men	22	68	23	general	treated	L
Afghanistan 	45-59	Men	33	91	35	general	treated	L
Afghanistan 	60-79	Men	29	72	30	general	treated	L
Afghanistan 	15-29	Men	7	91	12	general	controlled	L
Afghanistan 	30-44	Men	10	68	22	general	controlled	L
Afghanistan 	45-59	Men	12	91	33	general	controlled	L
Afghanistan 	60-79	Men	9	72	29	general	controlled	L
Afghanistan 	all ages	Men	326	2008	2008	general	prevalence	L
Afghanistan 	all ages	Men	137	2008	326	general	tested	L
Afghanistan 	all ages	Men	103	2008	137	general	diagnosed	L
Afghanistan 	all ages	Men	98	2008	103	general	treated	L
Afghanistan 	all ages	Men	38	2008	98	general	controlled	L
Algeria	15-29	Women	55	859	859	general	prevalence	LM
Algeria	30-44	Women	128	1562	1562	general	prevalence	LM
Algeria	45-59	Women	196	1021	1021	general	prevalence	LM
Algeria	60-79	Women	151	465	465	general	prevalence	LM
Algeria	15-29	Women	32	55	55	general	tested	LM
Algeria	30-44	Women	83	128	128	general	tested	LM
Algeria	45-59	Women	172	196	196	general	tested	LM
Algeria	60-79	Women	139	151	151	general	tested	LM
Algeria	15-29	Women	15	55	32	general	diagnosed	LM
Algeria	30-44	Women	52	128	83	general	diagnosed	LM
Algeria	45-59	Women	137	196	172	general	diagnosed	LM
Algeria	60-79	Women	118	151	139	general	diagnosed	LM
Algeria	15-29	Women	15	55	15	general	treated	LM
Algeria	30-44	Women	51	128	52	general	treated	LM
Algeria	45-59	Women	134	196	137	general	treated	LM
Algeria	60-79	Women	116	151	118	general	treated	LM
Algeria	15-29	Women	2	55	15	general	controlled	LM
Algeria	30-44	Women	14	128	51	general	controlled	LM
Algeria	45-59	Women	45	196	134	general	controlled	LM
Algeria	60-79	Women	33	151	116	general	controlled	LM
Algeria	all ages	Women	530	3907	3907	general	prevalence	LM
Algeria	all ages	Women	426	3907	530	general	tested	LM
Algeria	all ages	Women	322	3907	426	general	diagnosed	LM
Algeria	all ages	Women	316	3907	322	general	treated	LM
Algeria	all ages	Women	94	3907	316	general	controlled	LM
Algeria	15-29	Men	33	649	649	general	prevalence	LM
Algeria	30-44	Men	79	1185	1185	general	prevalence	LM
Algeria	45-59	Men	168	908	908	general	prevalence	LM
Algeria	60-79	Men	88	340	340	general	prevalence	LM
Algeria	15-29	Men	8	33	33	general	tested	LM
Algeria	30-44	Men	46	79	79	general	tested	LM
Algeria	45-59	Men	134	168	168	general	tested	LM
Algeria	60-79	Men	71	88	88	general	tested	LM
Algeria	15-29	Men	7	33	8	general	diagnosed	LM
Algeria	30-44	Men	31	79	46	general	diagnosed	LM
Algeria	45-59	Men	108	168	134	general	diagnosed	LM
Algeria	60-79	Men	57	88	71	general	diagnosed	LM
Algeria	15-29	Men	7	33	7	general	treated	LM
Algeria	30-44	Men	30	79	31	general	treated	LM
Algeria	45-59	Men	106	168	108	general	treated	LM
Algeria	60-79	Men	57	88	57	general	treated	LM
Algeria	15-29	Men	1	33	7	general	controlled	LM
Algeria	30-44	Men	11	79	30	general	controlled	LM
Algeria	45-59	Men	36	168	106	general	controlled	LM
Algeria	60-79	Men	14	88	57	general	controlled	LM
Algeria	all ages	Men	368	3082	3082	general	prevalence	LM
Algeria	all ages	Men	259	3082	368	general	tested	LM
Algeria	all ages	Men	203	3082	259	general	diagnosed	LM
Algeria	all ages	Men	200	3082	203	general	treated	LM
Algeria	all ages	Men	62	3082	200	general	controlled	LM
Bangladesh	15-29	Women	21	770	770	general	prevalence	LM
Bangladesh	30-44	Women	105	1539	1539	general	prevalence	LM
Bangladesh	45-59	Women	165	1126	1126	general	prevalence	LM
Bangladesh	60-79	Women	71	369	369	general	prevalence	LM
Bangladesh	15-29	Women	4	21	21	general	tested	LM
Bangladesh	30-44	Women	63	105	105	general	tested	LM
Bangladesh	45-59	Women	130	165	165	general	tested	LM
Bangladesh	60-79	Women	59	71	71	general	tested	LM
Bangladesh	15-29	Women	0	21	4	general	diagnosed	LM
Bangladesh	30-44	Women	47	105	63	general	diagnosed	LM
Bangladesh	45-59	Women	103	165	130	general	diagnosed	LM
Bangladesh	60-79	Women	49	71	59	general	diagnosed	LM
Bangladesh	15-29	Women	0	21	0	general	treated	LM
Bangladesh	30-44	Women	43	105	47	general	treated	LM
Bangladesh	45-59	Women	91	165	103	general	treated	LM
Bangladesh	60-79	Women	47	71	49	general	treated	LM
Bangladesh	15-29	Women	0	21	0	general	controlled	LM
Bangladesh	30-44	Women	16	105	43	general	controlled	LM
Bangladesh	45-59	Women	22	165	91	general	controlled	LM
Bangladesh	60-79	Women	10	71	47	general	controlled	LM
Bangladesh	all ages	Women	372	3804	3804	general	prevalence	LM
Bangladesh	all ages	Women	270	3804	372	general	tested	LM
Bangladesh	all ages	Women	205	3804	270	general	diagnosed	LM
Bangladesh	all ages	Women	179	3804	205	general	treated	LM
Bangladesh	all ages	Women	47	3804	179	general	controlled	LM
Bangladesh	15-29	Men	33	1172	1172	general	prevalence	LM
Bangladesh	30-44	Men	166	1966	1966	general	prevalence	LM
Bangladesh	45-59	Men	138	1026	1026	general	prevalence	LM
Bangladesh	60-79	Men	35	217	217	general	prevalence	LM
Bangladesh	15-29	Men	12	33	33	general	tested	LM
Bangladesh	30-44	Men	111	166	166	general	tested	LM
Bangladesh	45-59	Men	118	138	138	general	tested	LM
Bangladesh	60-79	Men	29	35	35	general	tested	LM
Bangladesh	15-29	Men	7	33	12	general	diagnosed	LM
Bangladesh	30-44	Men	81	166	111	general	diagnosed	LM
Bangladesh	45-59	Men	94	138	118	general	diagnosed	LM
Bangladesh	60-79	Men	23	35	29	general	diagnosed	LM
Bangladesh	15-29	Men	4	33	7	general	treated	LM
Bangladesh	30-44	Men	69	166	81	general	treated	LM
Bangladesh	45-59	Men	84	138	94	general	treated	LM
Bangladesh	60-79	Men	22	35	23	general	treated	LM
Bangladesh	15-29	Men	2	33	4	general	controlled	LM
Bangladesh	30-44	Men	13	166	69	general	controlled	LM
Bangladesh	45-59	Men	25	138	84	general	controlled	LM
Bangladesh	60-79	Men	7	35	22	general	controlled	LM
Bangladesh	all ages	Men	372	4381	4381	general	prevalence	LM
Bangladesh	all ages	Men	270	4381	372	general	tested	LM
Bangladesh	all ages	Men	205	4381	270	general	diagnosed	LM
Bangladesh	all ages	Men	179	4381	205	general	treated	LM
Bangladesh	all ages	Men	47	4381	179	general	controlled	LM
Belarus	15-29	Women	4	359	359	general	prevalence	H
Belarus	30-44	Women	18	817	817	general	prevalence	H
Belarus	45-59	Women	62	1092	1092	general	prevalence	H
Belarus	60-79	Women	86	655	655	general	prevalence	H
Belarus	15-29	Women	3	4	4	general	tested	H
Belarus	30-44	Women	17	18	18	general	tested	H
Belarus	45-59	Women	59	62	62	general	tested	H
Belarus	60-79	Women	85	86	86	general	tested	H
Belarus	15-29	Women	2	4	3	general	diagnosed	H
Belarus	30-44	Women	11	18	17	general	diagnosed	H
Belarus	45-59	Women	40	62	59	general	diagnosed	H
Belarus	60-79	Women	69	86	85	general	diagnosed	H
Belarus	15-29	Women	2	4	2	general	treated	H
Belarus	30-44	Women	11	18	11	general	treated	H
Belarus	45-59	Women	38	62	40	general	treated	H
Belarus	60-79	Women	65	86	69	general	treated	H
Belarus	15-29	Women	2	4	2	general	controlled	H
Belarus	30-44	Women	10	18	11	general	controlled	H
Belarus	45-59	Women	25	62	38	general	controlled	H
Belarus	60-79	Women	49	86	65	general	controlled	H
Belarus	all ages	Women	170	2923	2923	general	prevalence	H
Belarus	all ages	Women	164	2923	170	general	tested	H
Belarus	all ages	Women	122	2923	164	general	diagnosed	H
Belarus	all ages	Women	116	2923	122	general	treated	H
Belarus	all ages	Women	86	2923	116	general	controlled	H
Belarus	15-29	Men	3	332	332	general	prevalence	H
Belarus	30-44	Men	12	592	592	general	prevalence	H
Belarus	45-59	Men	48	812	812	general	prevalence	H
Belarus	60-79	Men	40	354	354	general	prevalence	H
Belarus	15-29	Men	3	3	3	general	tested	H
Belarus	30-44	Men	11	12	12	general	tested	H
Belarus	45-59	Men	47	48	48	general	tested	H
Belarus	60-79	Men	38	40	40	general	tested	H
Belarus	15-29	Men	1	3	3	general	diagnosed	H
Belarus	30-44	Men	6	12	11	general	diagnosed	H
Belarus	45-59	Men	34	48	47	general	diagnosed	H
Belarus	60-79	Men	32	40	38	general	diagnosed	H
Belarus	15-29	Men	1	3	1	general	treated	H
Belarus	30-44	Men	6	12	6	general	treated	H
Belarus	45-59	Men	32	48	34	general	treated	H
Belarus	60-79	Men	31	40	32	general	treated	H
Belarus	15-29	Men	1	3	1	general	controlled	H
Belarus	30-44	Men	6	12	6	general	controlled	H
Belarus	45-59	Men	23	48	32	general	controlled	H
Belarus	60-79	Men	26	40	31	general	controlled	H
Belarus	all ages	Men	103	2090	2090	general	prevalence	H
Belarus	all ages	Men	99	2090	103	general	tested	H
Belarus	all ages	Men	73	2090	99	general	diagnosed	H
Belarus	all ages	Men	70	2090	73	general	treated	H
Belarus	all ages	Men	56	2090	70	general	controlled	H
Benin	15-29	Women	37	969	969	general	prevalence	L
Benin	30-44	Women	69	1123	1123	general	prevalence	L
Benin	45-59	Women	60	512	512	general	prevalence	L
Benin	60-79	Women	24	196	196	general	prevalence	L
Benin	15-29	Women	1	37	37	general	tested	L
Benin	30-44	Women	7	69	69	general	tested	L
Benin	45-59	Women	15	60	60	general	tested	L
Benin	60-79	Women	3	24	24	general	tested	L
Benin	15-29	Women	0	37	1	general	diagnosed	L
Benin	30-44	Women	3	69	7	general	diagnosed	L
Benin	45-59	Women	10	60	15	general	diagnosed	L
Benin	60-79	Women	3	24	3	general	diagnosed	L
Benin	15-29	Women	0	37	0	general	treated	L
Benin	30-44	Women	2	69	3	general	treated	L
Benin	45-59	Women	10	60	10	general	treated	L
Benin	60-79	Women	3	24	3	general	treated	L
Benin	15-29	Women	0	37	0	general	controlled	L
Benin	30-44	Women	1	69	2	general	controlled	L
Benin	45-59	Women	4	60	10	general	controlled	L
Benin	60-79	Women	1	24	3	general	controlled	L
Benin	all ages	Women	190	2800	2800	general	prevalence	L
Benin	all ages	Women	26	2800	190	general	tested	L
Benin	all ages	Women	16	2800	26	general	diagnosed	L
Benin	all ages	Women	15	2800	16	general	treated	L
Benin	all ages	Women	6	2800	15	general	controlled	L
Benin	15-29	Men	25	665	665	general	prevalence	L
Benin	30-44	Men	45	886	886	general	prevalence	L
Benin	45-59	Men	53	564	564	general	prevalence	L
Benin	60-79	Men	16	211	211	general	prevalence	L
Benin	15-29	Men	0	25	25	general	tested	L
Benin	30-44	Men	4	45	45	general	tested	L
Benin	45-59	Men	13	53	53	general	tested	L
Benin	60-79	Men	4	16	16	general	tested	L
Benin	15-29	Men	0	25	0	general	diagnosed	L
Benin	30-44	Men	2	45	4	general	diagnosed	L
Benin	45-59	Men	10	53	13	general	diagnosed	L
Benin	60-79	Men	3	16	4	general	diagnosed	L
Benin	15-29	Men	0	25	0	general	treated	L
Benin	30-44	Men	2	45	2	general	treated	L
Benin	45-59	Men	9	53	10	general	treated	L
Benin	60-79	Men	3	16	3	general	treated	L
Benin	15-29	Men	0	25	0	general	controlled	L
Benin	30-44	Men	0	45	2	general	controlled	L
Benin	45-59	Men	3	53	9	general	controlled	L
Benin	60-79	Men	2	16	3	general	controlled	L
Benin	all ages	Men	139	2326	2326	general	prevalence	L
Benin	all ages	Men	21	2326	139	general	tested	L
Benin	all ages	Men	15	2326	21	general	diagnosed	L
Benin	all ages	Men	14	2326	15	general	treated	L
Benin	all ages	Men	5	2326	14	general	controlled	L
Botswana	15-29	Women	8	1003	1003	general	prevalence	UM
Botswana	30-44	Women	18	930	930	general	prevalence	UM
Botswana	45-59	Women	43	586	586	general	prevalence	UM
Botswana	60-79	Women	34	232	232	general	prevalence	UM
Botswana	15-29	Women	2	8	8	general	tested	UM
Botswana	30-44	Women	6	18	18	general	tested	UM
Botswana	45-59	Women	30	43	43	general	tested	UM
Botswana	60-79	Women	25	34	34	general	tested	UM
Botswana	15-29	Women	2	8	2	general	diagnosed	UM
Botswana	30-44	Women	2	18	6	general	diagnosed	UM
Botswana	45-59	Women	23	43	30	general	diagnosed	UM
Botswana	60-79	Women	22	34	25	general	diagnosed	UM
Botswana	15-29	Women	2	8	2	general	treated	UM
Botswana	30-44	Women	2	18	2	general	treated	UM
Botswana	45-59	Women	22	43	23	general	treated	UM
Botswana	60-79	Women	22	34	22	general	treated	UM
Botswana	15-29	Women	1	8	2	general	controlled	UM
Botswana	30-44	Women	2	18	2	general	controlled	UM
Botswana	45-59	Women	13	43	22	general	controlled	UM
Botswana	60-79	Women	15	34	22	general	controlled	UM
Botswana	all ages	Women	103	2751	2751	general	prevalence	UM
Botswana	all ages	Women	63	2751	103	general	tested	UM
Botswana	all ages	Women	49	2751	63	general	diagnosed	UM
Botswana	all ages	Women	48	2751	49	general	treated	UM
Botswana	all ages	Women	31	2751	48	general	controlled	UM
Botswana	15-29	Men	5	562	562	general	prevalence	UM
Botswana	30-44	Men	8	420	420	general	prevalence	UM
Botswana	45-59	Men	16	248	248	general	prevalence	UM
Botswana	60-79	Men	10	89	89	general	prevalence	UM
Botswana	15-29	Men	0	5	5	general	tested	UM
Botswana	30-44	Men	7	8	8	general	tested	UM
Botswana	45-59	Men	11	16	16	general	tested	UM
Botswana	60-79	Men	8	10	10	general	tested	UM
Botswana	15-29	Men	0	5	0	general	diagnosed	UM
Botswana	30-44	Men	5	8	7	general	diagnosed	UM
Botswana	45-59	Men	8	16	11	general	diagnosed	UM
Botswana	60-79	Men	7	10	8	general	diagnosed	UM
Botswana	15-29	Men	0	5	0	general	treated	UM
Botswana	30-44	Men	5	8	5	general	treated	UM
Botswana	45-59	Men	8	16	8	general	treated	UM
Botswana	60-79	Men	7	10	7	general	treated	UM
Botswana	15-29	Men	0	5	0	general	controlled	UM
Botswana	30-44	Men	1	8	5	general	controlled	UM
Botswana	45-59	Men	3	16	8	general	controlled	UM
Botswana	60-79	Men	4	10	7	general	controlled	UM
Botswana	all ages	Men	39	1319	1319	general	prevalence	UM
Botswana	all ages	Men	26	1319	39	general	tested	UM
Botswana	all ages	Men	20	1319	26	general	diagnosed	UM
Botswana	all ages	Men	20	1319	20	general	treated	UM
Botswana	all ages	Men	8	1319	20	general	controlled	UM
Brunei	15-29	Women	13	529	529	general	prevalence	H
Brunei	30-44	Women	46	681	681	general	prevalence	H
Brunei	45-59	Women	126	647	647	general	prevalence	H
Brunei	60-79	Women	72	274	274	general	prevalence	H
Brunei	15-29	Women	11	13	13	general	tested	H
Brunei	30-44	Women	41	46	46	general	tested	H
Brunei	45-59	Women	122	126	126	general	tested	H
Brunei	60-79	Women	70	72	72	general	tested	H
Brunei	15-29	Women	7	13	11	general	diagnosed	H
Brunei	30-44	Women	32	46	41	general	diagnosed	H
Brunei	45-59	Women	115	126	122	general	diagnosed	H
Brunei	60-79	Women	62	72	70	general	diagnosed	H
Brunei	15-29	Women	7	13	7	general	treated	H
Brunei	30-44	Women	32	46	32	general	treated	H
Brunei	45-59	Women	115	126	115	general	treated	H
Brunei	60-79	Women	62	72	62	general	treated	H
Brunei	15-29	Women	2	13	7	general	controlled	H
Brunei	30-44	Women	7	46	32	general	controlled	H
Brunei	45-59	Women	47	126	115	general	controlled	H
Brunei	60-79	Women	24	72	62	general	controlled	H
Brunei	all ages	Women	257	2131	2131	general	prevalence	H
Brunei	all ages	Women	244	2131	257	general	tested	H
Brunei	all ages	Women	216	2131	244	general	diagnosed	H
Brunei	all ages	Women	216	2131	216	general	treated	H
Brunei	all ages	Women	80	2131	216	general	controlled	H
Brunei	15-29	Men	9	455	455	general	prevalence	H
Brunei	30-44	Men	32	446	446	general	prevalence	H
Brunei	45-59	Men	103	498	498	general	prevalence	H
Brunei	60-79	Men	75	278	278	general	prevalence	H
Brunei	15-29	Men	6	9	9	general	tested	H
Brunei	30-44	Men	29	32	32	general	tested	H
Brunei	45-59	Men	102	103	103	general	tested	H
Brunei	60-79	Men	73	75	75	general	tested	H
Brunei	15-29	Men	4	9	6	general	diagnosed	H
Brunei	30-44	Men	24	32	29	general	diagnosed	H
Brunei	45-59	Men	90	103	102	general	diagnosed	H
Brunei	60-79	Men	69	75	73	general	diagnosed	H
Brunei	15-29	Men	4	9	4	general	treated	H
Brunei	30-44	Men	23	32	24	general	treated	H
Brunei	45-59	Men	88	103	90	general	treated	H
Brunei	60-79	Men	69	75	69	general	treated	H
Brunei	15-29	Men	1	9	4	general	controlled	H
Brunei	30-44	Men	4	32	23	general	controlled	H
Brunei	45-59	Men	28	103	88	general	controlled	H
Brunei	60-79	Men	31	75	69	general	controlled	H
Brunei	all ages	Men	219	1677	1677	general	prevalence	H
Brunei	all ages	Men	210	1677	219	general	tested	H
Brunei	all ages	Men	187	1677	210	general	diagnosed	H
Brunei	all ages	Men	184	1677	187	general	treated	H
Brunei	all ages	Men	64	1677	184	general	controlled	H
Cabo Verde	15-29	Women	4	643	643	general	prevalence	UM
Cabo Verde	30-44	Women	29	960	960	general	prevalence	UM
Cabo Verde	45-59	Women	65	722	722	general	prevalence	UM
Cabo Verde	60-79	Women	56	397	397	general	prevalence	UM
Cabo Verde	15-29	Women	2	4	4	general	tested	UM
Cabo Verde	30-44	Women	23	29	29	general	tested	UM
Cabo Verde	45-59	Women	60	65	65	general	tested	UM
Cabo Verde	60-79	Women	54	56	56	general	tested	UM
Cabo Verde	15-29	Women	1	4	2	general	diagnosed	UM
Cabo Verde	30-44	Women	13	29	23	general	diagnosed	UM
Cabo Verde	45-59	Women	49	65	60	general	diagnosed	UM
Cabo Verde	60-79	Women	50	56	54	general	diagnosed	UM
Cabo Verde	15-29	Women	1	4	1	general	treated	UM
Cabo Verde	30-44	Women	13	29	13	general	treated	UM
Cabo Verde	45-59	Women	46	65	49	general	treated	UM
Cabo Verde	60-79	Women	49	56	50	general	treated	UM
Cabo Verde	15-29	Women	0	4	1	general	controlled	UM
Cabo Verde	30-44	Women	2	29	13	general	controlled	UM
Cabo Verde	45-59	Women	6	65	46	general	controlled	UM
Cabo Verde	60-79	Women	12	56	49	general	controlled	UM
Cabo Verde	all ages	Women	154	2722	2722	general	prevalence	UM
Cabo Verde	all ages	Women	139	2722	154	general	tested	UM
Cabo Verde	all ages	Women	113	2722	139	general	diagnosed	UM
Cabo Verde	all ages	Women	109	2722	113	general	treated	UM
Cabo Verde	all ages	Women	20	2722	109	general	controlled	UM
Cabo Verde	15-29	Men	4	464	464	general	prevalence	UM
Cabo Verde	30-44	Men	29	648	648	general	prevalence	UM
Cabo Verde	45-59	Men	65	517	517	general	prevalence	UM
Cabo Verde	60-79	Men	56	212	212	general	prevalence	UM
Cabo Verde	15-29	Men	2	4	4	general	tested	UM
Cabo Verde	30-44	Men	4	29	29	general	tested	UM
Cabo Verde	45-59	Men	29	65	65	general	tested	UM
Cabo Verde	60-79	Men	26	56	56	general	tested	UM
Cabo Verde	15-29	Men	2	4	2	general	diagnosed	UM
Cabo Verde	30-44	Men	4	29	4	general	diagnosed	UM
Cabo Verde	45-59	Men	23	65	29	general	diagnosed	UM
Cabo Verde	60-79	Men	25	56	26	general	diagnosed	UM
Cabo Verde	15-29	Men	2	4	2	general	treated	UM
Cabo Verde	30-44	Men	4	29	4	general	treated	UM
Cabo Verde	45-59	Men	22	65	23	general	treated	UM
Cabo Verde	60-79	Men	25	56	25	general	treated	UM
Cabo Verde	15-29	Men	1	4	2	general	controlled	UM
Cabo Verde	30-44	Men	0	29	4	general	controlled	UM
Cabo Verde	45-59	Men	8	65	22	general	controlled	UM
Cabo Verde	60-79	Men	5	56	25	general	controlled	UM
Cabo Verde	all ages	Men	70	1841	1841	general	prevalence	UM
Cabo Verde	all ages	Men	61	1841	70	general	tested	UM
Cabo Verde	all ages	Men	54	1841	61	general	diagnosed	UM
Cabo Verde	all ages	Men	53	1841	54	general	treated	UM
Cabo Verde	all ages	Men	14	1841	53	general	controlled	UM
Ecuador	15-29	Women	9	681	681	general	prevalence	LM
Ecuador	30-44	Women	49	976	976	general	prevalence	LM
Ecuador	45-59	Women	88	689	689	general	prevalence	LM
Ecuador	60-79	Women	55	348	348	general	prevalence	LM
Ecuador	15-29	Women	5	9	9	general	tested	LM
Ecuador	30-44	Women	36	49	49	general	tested	LM
Ecuador	45-59	Women	65	88	88	general	tested	LM
Ecuador	60-79	Women	48	55	55	general	tested	LM
Ecuador	15-29	Women	1	9	5	general	diagnosed	LM
Ecuador	30-44	Women	17	49	36	general	diagnosed	LM
Ecuador	45-59	Women	42	88	65	general	diagnosed	LM
Ecuador	60-79	Women	39	55	48	general	diagnosed	LM
Ecuador	15-29	Women	1	9	1	general	treated	LM
Ecuador	30-44	Women	16	49	17	general	treated	LM
Ecuador	45-59	Women	41	88	42	general	treated	LM
Ecuador	60-79	Women	37	55	39	general	treated	LM
Ecuador	15-29	Women	0	9	1	general	controlled	LM
Ecuador	30-44	Women	5	49	16	general	controlled	LM
Ecuador	45-59	Women	13	88	41	general	controlled	LM
Ecuador	60-79	Women	14	55	37	general	controlled	LM
Ecuador	all ages	Women	201	2694	2694	general	prevalence	LM
Ecuador	all ages	Women	154	2694	201	general	tested	LM
Ecuador	all ages	Women	99	2694	99	general	diagnosed	LM
Ecuador	all ages	Women	95	2694	95	general	treated	LM
Ecuador	all ages	Women	32	2694	32	general	controlled	LM
Ecuador	15-29	Men	4	524	524	general	prevalence	LM
Ecuador	30-44	Men	38	620	620	general	prevalence	LM
Ecuador	45-59	Men	65	544	544	general	prevalence	LM
Ecuador	60-79	Men	44	256	256	general	prevalence	LM
Ecuador	15-29	Men	3	4	4	general	tested	LM
Ecuador	30-44	Men	27	38	38	general	tested	LM
Ecuador	45-59	Men	46	65	65	general	tested	LM
Ecuador	60-79	Men	37	44	44	general	tested	LM
Ecuador	15-29	Men	0	4	3	general	diagnosed	LM
Ecuador	30-44	Men	13	38	27	general	diagnosed	LM
Ecuador	45-59	Men	30	65	46	general	diagnosed	LM
Ecuador	60-79	Men	30	44	37	general	diagnosed	LM
Ecuador	15-29	Men	0	4	0	general	treated	LM
Ecuador	30-44	Men	13	38	13	general	treated	LM
Ecuador	45-59	Men	30	65	30	general	treated	LM
Ecuador	60-79	Men	29	44	30	general	treated	LM
Ecuador	15-29	Men	0	4	0	general	controlled	LM
Ecuador	30-44	Men	6	38	13	general	controlled	LM
Ecuador	45-59	Men	10	65	30	general	controlled	LM
Ecuador	60-79	Men	13	44	29	general	controlled	LM
Ecuador	all ages	Men	151	1944	1944	general	prevalence	LM
Ecuador	all ages	Men	113	1944	151	general	tested	LM
Ecuador	all ages	Men	73	1944	113	general	diagnosed	LM
Ecuador	all ages	Men	72	1944	73	general	treated	LM
Ecuador	all ages	Men	29	1944	72	general	controlled	LM
Eswatini	15-29	Women	14	876	876	general	prevalence	UM
Eswatini	30-44	Women	29	688	688	general	prevalence	UM
Eswatini	45-59	Women	50	487	487	general	prevalence	UM
Eswatini	60-79	Women	44	253	253	general	prevalence	UM
Eswatini	15-29	Women	1	14	14	general	tested	UM
Eswatini	30-44	Women	9	29	29	general	tested	UM
Eswatini	45-59	Women	31	50	50	general	tested	UM
Eswatini	60-79	Women	25	44	44	general	tested	UM
Eswatini	15-29	Women	0	14	1	general	diagnosed	UM
Eswatini	30-44	Women	7	29	9	general	diagnosed	UM
Eswatini	45-59	Women	21	50	31	general	diagnosed	UM
Eswatini	60-79	Women	22	44	25	general	diagnosed	UM
Eswatini	15-29	Women	0	14	0	general	treated	UM
Eswatini	30-44	Women	7	29	7	general	treated	UM
Eswatini	45-59	Women	19	50	21	general	treated	UM
Eswatini	60-79	Women	21	44	22	general	treated	UM
Eswatini	15-29	Women	0	14	0	general	controlled	UM
Eswatini	30-44	Women	1	29	7	general	controlled	UM
Eswatini	45-59	Women	9	50	19	general	controlled	UM
Eswatini	60-79	Women	10	44	21	general	controlled	UM
Eswatini	all ages	Women	137	2304	2304	general	prevalence	UM
Eswatini	all ages	Women	66	2304	137	general	tested	UM
Eswatini	all ages	Women	50	2304	66	general	diagnosed	UM
Eswatini	all ages	Women	47	2304	50	general	treated	UM
Eswatini	all ages	Women	20	2304	47	general	controlled	UM
Eswatini	15-29	Men	6	567	567	general	prevalence	UM
Eswatini	30-44	Men	9	325	325	general	prevalence	UM
Eswatini	45-59	Men	17	218	218	general	prevalence	UM
Eswatini	60-79	Men	18	120	120	general	prevalence	UM
Eswatini	15-29	Men	2	6	6	general	tested	UM
Eswatini	30-44	Men	5	9	9	general	tested	UM
Eswatini	45-59	Men	13	17	17	general	tested	UM
Eswatini	60-79	Men	13	18	18	general	tested	UM
Eswatini	15-29	Men	0	6	2	general	diagnosed	UM
Eswatini	30-44	Men	3	9	5	general	diagnosed	UM
Eswatini	45-59	Men	10	17	13	general	diagnosed	UM
Eswatini	60-79	Men	12	18	13	general	diagnosed	UM
Eswatini	15-29	Men	0	6	0	general	treated	UM
Eswatini	30-44	Men	3	9	3	general	treated	UM
Eswatini	45-59	Men	10	17	10	general	treated	UM
Eswatini	60-79	Men	12	18	12	general	treated	UM
Eswatini	15-29	Men	0	6	0	general	controlled	UM
Eswatini	30-44	Men	3	9	3	general	controlled	UM
Eswatini	45-59	Men	8	17	10	general	controlled	UM
Eswatini	60-79	Men	6	18	12	general	controlled	UM
Eswatini	all ages	Men	50	1230	1230	general	prevalence	UM
Eswatini	all ages	Men	33	1230	50	general	tested	UM
Eswatini	all ages	Men	25	1230	33	general	diagnosed	UM
Eswatini	all ages	Men	25	1230	25	general	treated	UM
Eswatini	all ages	Men	17	1230	25	general	controlled	UM
Ethopia	15-29	Women	44	2518	2518	general	prevalence	L
Ethopia	30-44	Women	49	2061	2061	general	prevalence	L
Ethopia	45-59	Women	41	909	909	general	prevalence	L
Ethopia	60-79	Women	25	335	335	general	prevalence	L
Ethopia	15-29	Women	3	44	44	general	tested	L
Ethopia	30-44	Women	11	49	49	general	tested	L
Ethopia	45-59	Women	21	41	41	general	tested	L
Ethopia	60-79	Women	16	25	25	general	tested	L
Ethopia	15-29	Women	2	44	3	general	diagnosed	L
Ethopia	30-44	Women	8	49	11	general	diagnosed	L
Ethopia	45-59	Women	19	41	21	general	diagnosed	L
Ethopia	60-79	Women	12	25	16	general	diagnosed	L
Ethopia	15-29	Women	2	44	2	general	treated	L
Ethopia	30-44	Women	8	49	8	general	treated	L
Ethopia	45-59	Women	18	41	19	general	treated	L
Ethopia	60-79	Women	11	25	12	general	treated	L
Ethopia	15-29	Women	2	44	2	general	controlled	L
Ethopia	30-44	Women	1	49	8	general	controlled	L
Ethopia	45-59	Women	6	41	18	general	controlled	L
Ethopia	60-79	Women	7	25	11	general	controlled	L
Ethopia	all ages	Women	159	5823	5823	general	prevalence	L
Ethopia	all ages	Women	51	5823	159	general	tested	L
Ethopia	all ages	Women	41	5823	51	general	diagnosed	L
Ethopia	all ages	Women	39	5823	41	general	treated	L
Ethopia	all ages	Women	16	5823	39	general	controlled	L
Ethopia	15-29	Men	28	1441	1441	general	prevalence	L
Ethopia	30-44	Men	48	1438	1438	general	prevalence	L
Ethopia	45-59	Men	35	781	781	general	prevalence	L
Ethopia	60-79	Men	25	317	317	general	prevalence	L
Ethopia	15-29	Men	2	28	28	general	tested	L
Ethopia	30-44	Men	9	48	48	general	tested	L
Ethopia	45-59	Men	13	35	35	general	tested	L
Ethopia	60-79	Men	13	25	25	general	tested	L
Ethopia	15-29	Men	2	28	2	general	diagnosed	L
Ethopia	30-44	Men	6	48	9	general	diagnosed	L
Ethopia	45-59	Men	13	35	13	general	diagnosed	L
Ethopia	60-79	Men	10	25	13	general	diagnosed	L
Ethopia	15-29	Men	2	28	2	general	treated	L
Ethopia	30-44	Men	4	48	6	general	treated	L
Ethopia	45-59	Men	13	35	13	general	treated	L
Ethopia	60-79	Men	10	25	10	general	treated	L
Ethopia	15-29	Men	1	28	2	general	controlled	L
Ethopia	30-44	Men	1	48	4	general	controlled	L
Ethopia	45-59	Men	3	35	13	general	controlled	L
Ethopia	60-79	Men	4	25	10	general	controlled	L
Ethopia	all ages	Men	136	3977	3977	general	prevalence	L
Ethopia	all ages	Men	37	3977	136	general	tested	L
Ethopia	all ages	Men	31	3977	37	general	diagnosed	L
Ethopia	all ages	Men	29	3977	31	general	treated	L
Ethopia	all ages	Men	9	3977	29	general	controlled	L
Georgia	15-29	Women	1	391	391	general	prevalence	LM
Georgia	30-44	Women	14	723	723	general	prevalence	LM
Georgia	45-59	Women	87	1063	1063	general	prevalence	LM
Georgia	60-79	Women	106	756	756	general	prevalence	LM
Georgia	15-29	Women	1	1	1	general	tested	LM
Georgia	30-44	Women	11	14	14	general	tested	LM
Georgia	45-59	Women	72	87	87	general	tested	LM
Georgia	60-79	Women	89	106	106	general	tested	LM
Georgia	15-29	Women	1	1	1	general	diagnosed	LM
Georgia	30-44	Women	8	14	11	general	diagnosed	LM
Georgia	45-59	Women	61	87	72	general	diagnosed	LM
Georgia	60-79	Women	75	106	89	general	diagnosed	LM
Georgia	15-29	Women	1	1	1	general	treated	LM
Georgia	30-44	Women	6	14	8	general	treated	LM
Georgia	45-59	Women	60	87	61	general	treated	LM
Georgia	60-79	Women	73	106	75	general	treated	LM
Georgia	15-29	Women	0	1	1	general	controlled	LM
Georgia	30-44	Women	4	14	6	general	controlled	LM
Georgia	45-59	Women	30	87	60	general	controlled	LM
Georgia	60-79	Women	43	106	73	general	controlled	LM
Georgia	all ages	Women	208	2933	2933	general	prevalence	LM
Georgia	all ages	Women	173	2933	208	general	tested	LM
Georgia	all ages	Women	145	2933	173	general	diagnosed	LM
Georgia	all ages	Women	140	2933	145	general	treated	LM
Georgia	all ages	Women	77	2933	140	general	controlled	LM
Georgia	15-29	Men	4	218	218	general	prevalence	LM
Georgia	30-44	Men	5	327	327	general	prevalence	LM
Georgia	45-59	Men	50	449	449	general	prevalence	LM
Georgia	60-79	Men	36	277	277	general	prevalence	LM
Georgia	15-29	Men	2	4	4	general	tested	LM
Georgia	30-44	Men	3	5	5	general	tested	LM
Georgia	45-59	Men	38	50	50	general	tested	LM
Georgia	60-79	Men	34	36	36	general	tested	LM
Georgia	15-29	Men	2	4	2	general	diagnosed	LM
Georgia	30-44	Men	3	5	3	general	diagnosed	LM
Georgia	45-59	Men	34	50	38	general	diagnosed	LM
Georgia	60-79	Men	29	36	34	general	diagnosed	LM
Georgia	15-29	Men	2	4	2	general	treated	LM
Georgia	30-44	Men	3	5	3	general	treated	LM
Georgia	45-59	Men	33	50	34	general	treated	LM
Georgia	60-79	Men	28	36	29	general	treated	LM
Georgia	15-29	Men	0	4	2	general	controlled	LM
Georgia	30-44	Men	1	5	3	general	controlled	LM
Georgia	45-59	Men	20	50	33	general	controlled	LM
Georgia	60-79	Men	18	36	28	general	controlled	LM
Georgia	all ages	Men	95	1271	1271	general	prevalence	LM
Georgia	all ages	Men	77	1271	95	general	tested	LM
Georgia	all ages	Men	68	1271	77	general	diagnosed	LM
Georgia	all ages	Men	66	1271	68	general	treated	LM
Georgia	all ages	Men	39	1271	66	general	controlled	LM
Guyana	15-29	Women	6	455	455	general	prevalence	LM
Guyana	30-44	Women	39	545	545	general	prevalence	LM
Guyana	45-59	Women	78	408	408	general	prevalence	LM
Guyana	60-79	Women	60	186	186	general	prevalence	LM
Guyana	15-29	Women	5	6	6	general	tested	LM
Guyana	30-44	Women	32	39	39	general	tested	LM
Guyana	45-59	Women	72	78	78	general	tested	LM
Guyana	60-79	Women	59	60	60	general	tested	LM
Guyana	15-29	Women	2	6	5	general	diagnosed	LM
Guyana	30-44	Women	26	39	32	general	diagnosed	LM
Guyana	45-59	Women	66	78	72	general	diagnosed	LM
Guyana	60-79	Women	56	60	59	general	diagnosed	LM
Guyana	15-29	Women	2	6	2	general	treated	LM
Guyana	30-44	Women	26	39	26	general	treated	LM
Guyana	45-59	Women	66	78	66	general	treated	LM
Guyana	60-79	Women	54	60	56	general	treated	LM
Guyana	15-29	Women	0	6	2	general	controlled	LM
Guyana	30-44	Women	2	39	26	general	controlled	LM
Guyana	45-59	Women	11	78	66	general	controlled	LM
Guyana	60-79	Women	8	60	54	general	controlled	LM
Guyana	all ages	Women	183	1594	1594	general	prevalence	LM
Guyana	all ages	Women	168	1594	183	general	tested	LM
Guyana	all ages	Women	150	1594	168	general	diagnosed	LM
Guyana	all ages	Women	148	1594	150	general	treated	LM
Guyana	all ages	Women	21	1594	148	general	controlled	LM
Guyana	15-29	Men	3	275	275	general	prevalence	LM
Guyana	30-44	Men	9	326	326	general	prevalence	LM
Guyana	45-59	Men	47	311	311	general	prevalence	LM
Guyana	60-79	Men	24	156	156	general	prevalence	LM
Guyana	15-29	Men	2	3	3	general	tested	LM
Guyana	30-44	Men	6	9	9	general	tested	LM
Guyana	45-59	Men	43	47	47	general	tested	LM
Guyana	60-79	Men	24	24	24	general	tested	LM
Guyana	15-29	Men	2	3	2	general	diagnosed	LM
Guyana	30-44	Men	5	9	6	general	diagnosed	LM
Guyana	45-59	Men	38	47	43	general	diagnosed	LM
Guyana	60-79	Men	22	24	24	general	diagnosed	LM
Guyana	15-29	Men	2	3	2	general	treated	LM
Guyana	30-44	Men	5	9	5	general	treated	LM
Guyana	45-59	Men	36	47	38	general	treated	LM
Guyana	60-79	Men	21	24	22	general	treated	LM
Guyana	15-29	Men	0	3	2	general	controlled	LM
Guyana	30-44	Men	2	9	5	general	controlled	LM
Guyana	45-59	Men	5	47	36	general	controlled	LM
Guyana	60-79	Men	2	24	21	general	controlled	LM
Guyana	all ages	Men	83	1068	1068	general	prevalence	LM
Guyana	all ages	Men	75	1068	83	general	tested	LM
Guyana	all ages	Men	67	1068	75	general	diagnosed	LM
Guyana	all ages	Men	64	1068	67	general	treated	LM
Guyana	all ages	Men	9	1068	64	general	controlled	LM
Iraq	15-29	Women	38	613	613	general	prevalence	UM
Iraq	30-44	Women	101	948	948	general	prevalence	UM
Iraq	45-59	Women	146	537	537	general	prevalence	UM
Iraq	60-79	Women	125	322	322	general	prevalence	UM
Iraq	15-29	Women	3	38	38	general	tested	UM
Iraq	30-44	Women	16	101	101	general	tested	UM
Iraq	45-59	Women	21	146	146	general	tested	UM
Iraq	60-79	Women	27	125	125	general	tested	UM
Iraq	15-29	Women	2	38	3	general	diagnosed	UM
Iraq	30-44	Women	13	101	16	general	diagnosed	UM
Iraq	45-59	Women	18	146	21	general	diagnosed	UM
Iraq	60-79	Women	22	125	27	general	diagnosed	UM
Iraq	15-29	Women	2	38	2	general	treated	UM
Iraq	30-44	Women	12	101	13	general	treated	UM
Iraq	45-59	Women	18	146	18	general	treated	UM
Iraq	60-79	Women	22	125	22	general	treated	UM
Iraq	15-29	Women	2	38	2	general	controlled	UM
Iraq	30-44	Women	6	101	12	general	controlled	UM
Iraq	45-59	Women	6	146	18	general	controlled	UM
Iraq	60-79	Women	1	125	22	general	controlled	UM
Iraq	all ages	Women	422	2420	2420	general	prevalence	UM
Iraq	all ages	Women	71	2420	422	general	tested	UM
Iraq	all ages	Women	58	2420	71	general	diagnosed	UM
Iraq	all ages	Women	57	2420	58	general	treated	UM
Iraq	all ages	Women	15	2420	57	general	controlled	UM
Iraq	15-29	Men	26	414	414	general	prevalence	UM
Iraq	30-44	Men	65	500	500	general	prevalence	UM
Iraq	45-59	Men	117	396	396	general	prevalence	UM
Iraq	60-79	Men	125	273	273	general	prevalence	UM
Iraq	15-29	Men	1	26	26	general	tested	UM
Iraq	30-44	Men	10	65	65	general	tested	UM
Iraq	45-59	Men	22	117	117	general	tested	UM
Iraq	60-79	Men	10	125	125	general	tested	UM
Iraq	15-29	Men	0	26	1	general	diagnosed	UM
Iraq	30-44	Men	8	65	10	general	diagnosed	UM
Iraq	45-59	Men	21	117	22	general	diagnosed	UM
Iraq	60-79	Men	10	125	10	general	diagnosed	UM
Iraq	15-29	Men	0	26	0	general	treated	UM
Iraq	30-44	Men	7	65	8	general	treated	UM
Iraq	45-59	Men	21	117	21	general	treated	UM
Iraq	60-79	Men	10	125	10	general	treated	UM
Iraq	15-29	Men	0	26	0	general	controlled	UM
Iraq	30-44	Men	2	65	7	general	controlled	UM
Iraq	45-59	Men	6	117	21	general	controlled	UM
Iraq	60-79	Men	2	125	10	general	controlled	UM
Iraq	all ages	Men	307	1583	1583	general	prevalence	UM
Iraq	all ages	Men	44	1583	307	general	tested	UM
Iraq	all ages	Men	39	1583	44	general	diagnosed	UM
Iraq	all ages	Men	38	1583	39	general	treated	UM
Iraq	all ages	Men	10	1583	38	general	controlled	UM
Jordan	15-29	Women	12	964	964	general	prevalence	LM
Jordan	30-44	Women	52	1392	1392	general	prevalence	LM
Jordan	45-59	Women	178	785	785	general	prevalence	LM
Jordan	60-79	Women	150	369	369	general	prevalence	LM
Jordan	15-29	Women	7	12	12	general	tested	LM
Jordan	30-44	Women	47	52	52	general	tested	LM
Jordan	45-59	Women	165	178	178	general	tested	LM
Jordan	60-79	Women	146	150	150	general	tested	LM
Jordan	15-29	Women	6	12	7	general	diagnosed	LM
Jordan	30-44	Women	42	52	47	general	diagnosed	LM
Jordan	45-59	Women	149	178	165	general	diagnosed	LM
Jordan	60-79	Women	143	150	146	general	diagnosed	LM
Jordan	15-29	Women	6	12	6	general	treated	LM
Jordan	30-44	Women	40	52	42	general	treated	LM
Jordan	45-59	Women	149	178	149	general	treated	LM
Jordan	60-79	Women	142	150	143	general	treated	LM
Jordan	15-29	Women	3	12	6	general	controlled	LM
Jordan	30-44	Women	24	52	40	general	controlled	LM
Jordan	45-59	Women	87	178	149	general	controlled	LM
Jordan	60-79	Women	77	150	142	general	controlled	LM
Jordan	all ages	Women	392	3510	3510	general	prevalence	LM
Jordan	all ages	Women	365	3510	392	general	tested	LM
Jordan	all ages	Women	340	3510	365	general	diagnosed	LM
Jordan	all ages	Women	337	3510	340	general	treated	LM
Jordan	all ages	Women	191	3510	337	general	controlled	LM
Jordan	15-29	Men	7	638	638	general	prevalence	LM
Jordan	30-44	Men	45	754	754	general	prevalence	LM
Jordan	45-59	Men	114	554	554	general	prevalence	LM
Jordan	60-79	Men	90	257	257	general	prevalence	LM
Jordan	15-29	Men	4	7	7	general	tested	LM
Jordan	30-44	Men	41	45	45	general	tested	LM
Jordan	45-59	Men	104	114	114	general	tested	LM
Jordan	60-79	Men	88	90	90	general	tested	LM
Jordan	15-29	Men	4	7	4	general	diagnosed	LM
Jordan	30-44	Men	38	45	41	general	diagnosed	LM
Jordan	45-59	Men	97	114	104	general	diagnosed	LM
Jordan	60-79	Men	83	90	88	general	diagnosed	LM
Jordan	15-29	Men	4	7	4	general	treated	LM
Jordan	30-44	Men	38	45	38	general	treated	LM
Jordan	45-59	Men	95	114	97	general	treated	LM
Jordan	60-79	Men	81	90	83	general	treated	LM
Jordan	15-29	Men	2	7	4	general	controlled	LM
Jordan	30-44	Men	16	45	38	general	controlled	LM
Jordan	45-59	Men	48	114	95	general	controlled	LM
Jordan	60-79	Men	49	90	81	general	controlled	LM
Jordan	all ages	Men	256	2203	2203	general	prevalence	LM
Jordan	all ages	Men	237	2203	256	general	tested	LM
Jordan	all ages	Men	222	2203	237	general	diagnosed	LM
Jordan	all ages	Men	218	2203	222	general	treated	LM
Jordan	all ages	Men	115	2203	218	general	controlled	LM
Kiribati	15-29	Women	7	361	361	general	prevalence	L
Kiribati	30-44	Women	54	435	435	general	prevalence	L
Kiribati	45-59	Women	62	267	267	general	prevalence	L
Kiribati	60-79	Women	24	107	107	general	prevalence	L
Kiribati	15-29	Women	4	7	7	general	tested	L
Kiribati	30-44	Women	29	54	54	general	tested	L
Kiribati	45-59	Women	41	62	62	general	tested	L
Kiribati	60-79	Women	14	24	24	general	tested	L
Kiribati	15-29	Women	3	7	4	general	diagnosed	L
Kiribati	30-44	Women	24	54	29	general	diagnosed	L
Kiribati	45-59	Women	27	62	41	general	diagnosed	L
Kiribati	60-79	Women	10	24	14	general	diagnosed	L
Kiribati	15-29	Women	2	7	3	general	treated	L
Kiribati	30-44	Women	24	54	24	general	treated	L
Kiribati	45-59	Women	25	62	27	general	treated	L
Kiribati	60-79	Women	10	24	10	general	treated	L
Kiribati	15-29	Women	1	7	2	general	controlled	L
Kiribati	30-44	Women	10	54	24	general	controlled	L
Kiribati	45-59	Women	7	62	25	general	controlled	L
Kiribati	60-79	Women	4	24	10	general	controlled	L
Kiribati	all ages	Women	146	1170	1170	general	prevalence	L
Kiribati	all ages	Women	88	1170	146	general	tested	L
Kiribati	all ages	Women	64	1170	88	general	diagnosed	L
Kiribati	all ages	Women	61	1170	64	general	treated	L
Kiribati	all ages	Women	22	1170	61	general	controlled	L
Kiribati	15-29	Men	14	321	321	general	prevalence	L
Kiribati	30-44	Men	39	335	335	general	prevalence	L
Kiribati	45-59	Men	40	260	260	general	prevalence	L
Kiribati	60-79	Men	16	70	70	general	prevalence	L
Kiribati	15-29	Men	5	14	14	general	tested	L
Kiribati	30-44	Men	24	39	39	general	tested	L
Kiribati	45-59	Men	28	40	40	general	tested	L
Kiribati	60-79	Men	7	16	16	general	tested	L
Kiribati	15-29	Men	3	14	5	general	diagnosed	L
Kiribati	30-44	Men	12	39	24	general	diagnosed	L
Kiribati	45-59	Men	19	40	28	general	diagnosed	L
Kiribati	60-79	Men	4	16	7	general	diagnosed	L
Kiribati	15-29	Men	3	14	3	general	treated	L
Kiribati	30-44	Men	11	39	12	general	treated	L
Kiribati	45-59	Men	18	40	19	general	treated	L
Kiribati	60-79	Men	4	16	4	general	treated	L
Kiribati	15-29	Men	2	14	3	general	controlled	L
Kiribati	30-44	Men	3	39	11	general	controlled	L
Kiribati	45-59	Men	6	40	18	general	controlled	L
Kiribati	60-79	Men	0	16	4	general	controlled	L
Kiribati	all ages	Men	109	986	986	general	prevalence	L
Kiribati	all ages	Men	64	986	109	general	tested	L
Kiribati	all ages	Men	38	986	64	general	diagnosed	L
Kiribati	all ages	Men	36	986	38	general	treated	L
Kiribati	all ages	Men	11	986	36	general	controlled	L
Kuwait	15-29	Women	26	781	781	general	prevalence	UM
Kuwait	30-44	Women	78	1014	1014	general	prevalence	UM
Kuwait	45-59	Women	146	531	531	general	prevalence	UM
Kuwait	60-79	Women	69	134	134	general	prevalence	UM
Kuwait	15-29	Women	25	26	26	general	tested	UM
Kuwait	30-44	Women	73	78	78	general	tested	UM
Kuwait	45-59	Women	141	146	146	general	tested	UM
Kuwait	60-79	Women	66	69	69	general	tested	UM
Kuwait	15-29	Women	14	26	25	general	diagnosed	UM
Kuwait	30-44	Women	48	78	73	general	diagnosed	UM
Kuwait	45-59	Women	120	146	141	general	diagnosed	UM
Kuwait	60-79	Women	61	69	66	general	diagnosed	UM
Kuwait	15-29	Women	14	26	14	general	treated	UM
Kuwait	30-44	Women	48	78	48	general	treated	UM
Kuwait	45-59	Women	118	146	120	general	treated	UM
Kuwait	60-79	Women	61	69	61	general	treated	UM
Kuwait	15-29	Women	6	26	14	general	controlled	UM
Kuwait	30-44	Women	22	78	48	general	controlled	UM
Kuwait	45-59	Women	55	146	118	general	controlled	UM
Kuwait	60-79	Women	28	69	61	general	controlled	UM
Kuwait	all ages	Women	319	2460	2460	general	prevalence	UM
Kuwait	all ages	Women	305	2460	319	general	tested	UM
Kuwait	all ages	Women	243	2460	305	general	diagnosed	UM
Kuwait	all ages	Women	241	2460	243	general	treated	UM
Kuwait	all ages	Women	111	2460	241	general	controlled	UM
Kuwait	15-29	Men	28	525	525	general	prevalence	UM
Kuwait	30-44	Men	57	507	507	general	prevalence	UM
Kuwait	45-59	Men	113	347	347	general	prevalence	UM
Kuwait	60-79	Men	39	79	79	general	prevalence	UM
Kuwait	15-29	Men	25	28	28	general	tested	UM
Kuwait	30-44	Men	49	57	57	general	tested	UM
Kuwait	45-59	Men	107	113	113	general	tested	UM
Kuwait	60-79	Men	36	39	39	general	tested	UM
Kuwait	15-29	Men	15	28	25	general	diagnosed	UM
Kuwait	30-44	Men	31	57	49	general	diagnosed	UM
Kuwait	45-59	Men	85	113	107	general	diagnosed	UM
Kuwait	60-79	Men	35	39	36	general	diagnosed	UM
Kuwait	15-29	Men	15	28	15	general	treated	UM
Kuwait	30-44	Men	31	57	31	general	treated	UM
Kuwait	45-59	Men	85	113	85	general	treated	UM
Kuwait	60-79	Men	35	39	35	general	treated	UM
Kuwait	15-29	Men	6	28	15	general	controlled	UM
Kuwait	30-44	Men	14	57	31	general	controlled	UM
Kuwait	45-59	Men	40	113	85	general	controlled	UM
Kuwait	60-79	Men	18	39	35	general	controlled	UM
Kuwait	all ages	Men	237	1458	1458	general	prevalence	UM
Kuwait	all ages	Men	217	1458	237	general	tested	UM
Kuwait	all ages	Men	166	1458	217	general	diagnosed	UM
Kuwait	all ages	Men	166	1458	166	general	treated	UM
Kuwait	all ages	Men	78	1458	166	general	controlled	UM
Kyrgyzstan	15-29	Women	1	256	256	general	prevalence	LM
Kyrgyzstan	30-44	Women	18	619	619	general	prevalence	LM
Kyrgyzstan	45-59	Women	56	624	624	general	prevalence	LM
Kyrgyzstan	60-79	Women	24	178	178	general	prevalence	LM
Kyrgyzstan	15-29	Women	1	1	1	general	tested	LM
Kyrgyzstan	30-44	Women	3	18	18	general	tested	LM
Kyrgyzstan	45-59	Women	40	56	56	general	tested	LM
Kyrgyzstan	60-79	Women	18	24	24	general	tested	LM
Kyrgyzstan	15-29	Women	1	1	1	general	diagnosed	LM
Kyrgyzstan	30-44	Women	2	18	3	general	diagnosed	LM
Kyrgyzstan	45-59	Women	35	56	40	general	diagnosed	LM
Kyrgyzstan	60-79	Women	14	24	18	general	diagnosed	LM
Kyrgyzstan	15-29	Women	1	1	1	general	treated	LM
Kyrgyzstan	30-44	Women	2	18	2	general	treated	LM
Kyrgyzstan	45-59	Women	35	56	35	general	treated	LM
Kyrgyzstan	60-79	Women	14	24	14	general	treated	LM
Kyrgyzstan	15-29	Women	0	1	1	general	controlled	LM
Kyrgyzstan	30-44	Women	2	18	2	general	controlled	LM
Kyrgyzstan	45-59	Women	19	56	35	general	controlled	LM
Kyrgyzstan	60-79	Women	6	24	14	general	controlled	LM
Kyrgyzstan	all ages	Women	99	1677	1677	general	prevalence	LM
Kyrgyzstan	all ages	Women	62	1677	99	general	tested	LM
Kyrgyzstan	all ages	Women	52	1677	62	general	diagnosed	LM
Kyrgyzstan	all ages	Women	52	1677	52	general	treated	LM
Kyrgyzstan	all ages	Women	27	1677	52	general	controlled	LM
Kyrgyzstan	15-29	Men	1	134	134	general	prevalence	LM
Kyrgyzstan	30-44	Men	14	343	343	general	prevalence	LM
Kyrgyzstan	45-59	Men	32	388	388	general	prevalence	LM
Kyrgyzstan	60-79	Men	9	81	81	general	prevalence	LM
Kyrgyzstan	15-29	Men	0	1	1	general	tested	LM
Kyrgyzstan	30-44	Men	5	14	14	general	tested	LM
Kyrgyzstan	45-59	Men	20	32	32	general	tested	LM
Kyrgyzstan	60-79	Men	5	9	9	general	tested	LM
Kyrgyzstan	15-29	Men	0	1	0	general	diagnosed	LM
Kyrgyzstan	30-44	Men	3	14	5	general	diagnosed	LM
Kyrgyzstan	45-59	Men	16	32	20	general	diagnosed	LM
Kyrgyzstan	60-79	Men	4	9	5	general	diagnosed	LM
Kyrgyzstan	15-29	Men	0	1	0	general	treated	LM
Kyrgyzstan	30-44	Men	3	14	3	general	treated	LM
Kyrgyzstan	45-59	Men	16	32	16	general	treated	LM
Kyrgyzstan	60-79	Men	4	9	4	general	treated	LM
Kyrgyzstan	15-29	Men	0	1	0	general	controlled	LM
Kyrgyzstan	30-44	Men	1	14	3	general	controlled	LM
Kyrgyzstan	45-59	Men	7	32	16	general	controlled	LM
Kyrgyzstan	60-79	Men	2	9	4	general	controlled	LM
Kyrgyzstan	all ages	Men	56	946	946	general	prevalence	LM
Kyrgyzstan	all ages	Men	30	946	56	general	tested	LM
Kyrgyzstan	all ages	Men	23	946	30	general	diagnosed	LM
Kyrgyzstan	all ages	Men	23	946	23	general	treated	LM
Kyrgyzstan	all ages	Men	10	946	23	general	controlled	LM
Lebanon	15-29	Women	6	964	964	general	prevalence	UM
Lebanon	30-44	Women	39	1392	1392	general	prevalence	UM
Lebanon	45-59	Women	145	785	785	general	prevalence	UM
Lebanon	60-79	Women	142	369	369	general	prevalence	UM
Lebanon	15-29	Women	6	6	6	general	tested	UM
Lebanon	30-44	Women	39	39	39	general	tested	UM
Lebanon	45-59	Women	145	145	145	general	tested	UM
Lebanon	60-79	Women	142	142	142	general	tested	UM
Lebanon	15-29	Women	6	6	6	general	diagnosed	UM
Lebanon	30-44	Women	39	39	39	general	diagnosed	UM
Lebanon	45-59	Women	145	145	145	general	diagnosed	UM
Lebanon	60-79	Women	142	142	142	general	diagnosed	UM
Lebanon	15-29	Women	6	6	6	general	treated	UM
Lebanon	30-44	Women	39	39	39	general	treated	UM
Lebanon	45-59	Women	145	145	145	general	treated	UM
Lebanon	60-79	Women	142	142	142	general	treated	UM
Lebanon	15-29	Women	3	6	6	general	controlled	UM
Lebanon	30-44	Women	28	39	39	general	controlled	UM
Lebanon	45-59	Women	111	145	145	general	controlled	UM
Lebanon	60-79	Women	108	142	142	general	controlled	UM
Lebanon	all ages	Women	332	1103	1103	general	prevalence	UM
Lebanon	all ages	Women	332	1103	332	general	tested	UM
Lebanon	all ages	Women	332	1103	332	general	diagnosed	UM
Lebanon	all ages	Women	332	1103	332	general	treated	UM
Lebanon	all ages	Women	250	1103	332	general	controlled	UM
Lebanon	15-29	Men	4	638	638	general	prevalence	UM
Lebanon	30-44	Men	37	754	754	general	prevalence	UM
Lebanon	45-59	Men	94	554	554	general	prevalence	UM
Lebanon	60-79	Men	81	257	257	general	prevalence	UM
Lebanon	15-29	Men	4	4	4	general	tested	UM
Lebanon	30-44	Men	37	37	37	general	tested	UM
Lebanon	45-59	Men	94	94	94	general	tested	UM
Lebanon	60-79	Men	81	81	81	general	tested	UM
Lebanon	15-29	Men	4	4	4	general	diagnosed	UM
Lebanon	30-44	Men	37	37	37	general	diagnosed	UM
Lebanon	45-59	Men	94	94	94	general	diagnosed	UM
Lebanon	60-79	Men	81	81	81	general	diagnosed	UM
Lebanon	15-29	Men	4	4	4	general	treated	UM
Lebanon	30-44	Men	37	37	37	general	treated	UM
Lebanon	45-59	Men	94	94	94	general	treated	UM
Lebanon	60-79	Men	81	81	81	general	treated	UM
Lebanon	15-29	Men	3	4	4	general	controlled	UM
Lebanon	30-44	Men	20	37	37	general	controlled	UM
Lebanon	45-59	Men	60	94	94	general	controlled	UM
Lebanon	60-79	Men	62	81	81	general	controlled	UM
Lebanon	all ages	Men	216	796	796	general	prevalence	UM
Lebanon	all ages	Men	216	796	216	general	tested	UM
Lebanon	all ages	Men	216	796	216	general	diagnosed	UM
Lebanon	all ages	Men	216	796	216	general	treated	UM
Lebanon	all ages	Men	145	796	216	general	controlled	UM
Malawi	15-29	Women	11	922	922	general	prevalence	L
Malawi	30-44	Women	26	980	980	general	prevalence	L
Malawi	45-59	Women	12	531	531	general	prevalence	L
Malawi	60-79	Women	12	269	269	general	prevalence	L
Malawi	15-29	Women	1	11	11	general	tested	L
Malawi	30-44	Women	4	26	26	general	tested	L
Malawi	45-59	Women	6	12	12	general	tested	L
Malawi	60-79	Women	8	12	12	general	tested	L
Malawi	15-29	Women	1	11	1	general	diagnosed	L
Malawi	30-44	Women	4	26	4	general	diagnosed	L
Malawi	45-59	Women	6	12	6	general	diagnosed	L
Malawi	60-79	Women	5	12	8	general	diagnosed	L
Malawi	15-29	Women	1	11	1	general	treated	L
Malawi	30-44	Women	4	26	4	general	treated	L
Malawi	45-59	Women	6	12	6	general	treated	L
Malawi	60-79	Women	5	12	5	general	treated	L
Malawi	15-29	Women	0	11	1	general	controlled	L
Malawi	30-44	Women	2	26	4	general	controlled	L
Malawi	45-59	Women	4	12	6	general	controlled	L
Malawi	60-79	Women	3	12	5	general	controlled	L
Malawi	all ages	Women	61	2707	2707	general	prevalence	L
Malawi	all ages	Women	19	2707	61	general	tested	L
Malawi	all ages	Women	16	2707	19	general	diagnosed	L
Malawi	all ages	Women	16	2707	16	general	treated	L
Malawi	all ages	Women	9	2707	16	general	controlled	L
Malawi	15-29	Men	4	449	449	general	prevalence	L
Malawi	30-44	Men	12	568	568	general	prevalence	L
Malawi	45-59	Men	5	324	324	general	prevalence	L
Malawi	60-79	Men	12	144	144	general	prevalence	L
Malawi	15-29	Men	0	4	4	general	tested	L
Malawi	30-44	Men	2	12	12	general	tested	L
Malawi	45-59	Men	0	5	5	general	tested	L
Malawi	60-79	Men	10	12	12	general	tested	L
Malawi	15-29	Men	0	4	0	general	diagnosed	L
Malawi	30-44	Men	1	12	2	general	diagnosed	L
Malawi	45-59	Men	0	5	0	general	diagnosed	L
Malawi	60-79	Men	8	12	10	general	diagnosed	L
Malawi	15-29	Men	0	4	0	general	treated	L
Malawi	30-44	Men	1	12	1	general	treated	L
Malawi	45-59	Men	0	5	0	general	treated	L
Malawi	60-79	Men	8	12	8	general	treated	L
Malawi	15-29	Men	0	4	0	general	controlled	L
Malawi	30-44	Men	1	12	1	general	controlled	L
Malawi	45-59	Men	0	5	0	general	controlled	L
Malawi	60-79	Men	5	12	8	general	controlled	L
Malawi	all ages	Men	33	1485	1485	general	prevalence	L
Malawi	all ages	Men	12	1485	33	general	tested	L
Malawi	all ages	Men	9	1485	12	general	diagnosed	L
Malawi	all ages	Men	9	1485	9	general	treated	L
Malawi	all ages	Men	6	1485	9	general	controlled	L
Morocco	15-29	Women	23	722	722	general	prevalence	LM
Morocco	30-44	Women	104	1228	1228	general	prevalence	LM
Morocco	45-59	Women	200	961	961	general	prevalence	LM
Morocco	60-79	Women	169	563	563	general	prevalence	LM
Morocco	15-29	Women	10	10	10	general	tested	LM
Morocco	30-44	Women	61	61	61	general	tested	LM
Morocco	45-59	Women	159	159	159	general	tested	LM
Morocco	60-79	Women	140	140	140	general	tested	LM
Morocco	15-29	Women	4	10	10	general	diagnosed	LM
Morocco	30-44	Women	35	61	61	general	diagnosed	LM
Morocco	45-59	Women	120	159	159	general	diagnosed	LM
Morocco	60-79	Women	106	140	140	general	diagnosed	LM
Morocco	15-29	Women	4	10	4	general	treated	LM
Morocco	30-44	Women	34	61	35	general	treated	LM
Morocco	45-59	Women	115	159	120	general	treated	LM
Morocco	60-79	Women	103	140	106	general	treated	LM
Morocco	15-29	Women	1	10	4	general	controlled	LM
Morocco	30-44	Women	7	61	34	general	controlled	LM
Morocco	45-59	Women	26	159	115	general	controlled	LM
Morocco	60-79	Women	30	140	103	general	controlled	LM
Morocco	all ages	Women	510	3538	3538	general	prevalence	LM
Morocco	all ages	Women	380	3538	510	general	tested	LM
Morocco	all ages	Women	271	3538	380	general	diagnosed	LM
Morocco	all ages	Women	262	3538	271	general	treated	LM
Morocco	all ages	Women	65	3538	262	general	controlled	LM
Morocco	15-29	Men	10	339	339	general	prevalence	LM
Morocco	30-44	Men	28	516	516	general	prevalence	LM
Morocco	45-59	Men	67	537	537	general	prevalence	LM
Morocco	60-79	Men	105	438	438	general	prevalence	LM
Morocco	15-29	Men	3	10	10	general	tested	LM
Morocco	30-44	Men	14	28	28	general	tested	LM
Morocco	45-59	Men	42	67	67	general	tested	LM
Morocco	60-79	Men	83	105	105	general	tested	LM
Morocco	15-29	Men	2	10	3	general	diagnosed	LM
Morocco	30-44	Men	11	28	14	general	diagnosed	LM
Morocco	45-59	Men	40	67	42	general	diagnosed	LM
Morocco	60-79	Men	66	105	83	general	diagnosed	LM
Morocco	15-29	Men	2	10	2	general	treated	LM
Morocco	30-44	Men	10	28	11	general	treated	LM
Morocco	45-59	Men	38	67	40	general	treated	LM
Morocco	60-79	Men	66	105	66	general	treated	LM
Morocco	15-29	Men	1	10	2	general	controlled	LM
Morocco	30-44	Men	2	28	10	general	controlled	LM
Morocco	45-59	Men	11	67	38	general	controlled	LM
Morocco	60-79	Men	25	105	66	general	controlled	LM
Morocco	all ages	Men	224	1891	1891	general	prevalence	LM
Morocco	all ages	Men	153	1891	224	general	tested	LM
Morocco	all ages	Men	128	1891	153	general	diagnosed	LM
Morocco	all ages	Men	125	1891	128	general	treated	LM
Morocco	all ages	Men	41	1891	125	general	controlled	LM
Myanmmar	15-29	Women	6	497	497	general	prevalence	L
Myanmmar	30-44	Women	99	2112	2112	general	prevalence	L
Myanmmar	45-59	Women	285	2219	2219	general	prevalence	L
Myanmmar	60-79	Women	105	551	551	general	prevalence	L
Myanmmar	15-29	Women	2	6	6	general	tested	L
Myanmmar	30-44	Women	58	99	99	general	tested	L
Myanmmar	45-59	Women	221	285	285	general	tested	L
Myanmmar	60-79	Women	76	105	105	general	tested	L
Myanmmar	15-29	Women	2	6	2	general	diagnosed	L
Myanmmar	30-44	Women	52	99	58	general	diagnosed	L
Myanmmar	45-59	Women	197	285	221	general	diagnosed	L
Myanmmar	60-79	Women	71	105	76	general	diagnosed	L
Myanmmar	15-29	Women	2	6	2	general	treated	L
Myanmmar	30-44	Women	51	99	52	general	treated	L
Myanmmar	45-59	Women	191	285	197	general	treated	L
Myanmmar	60-79	Women	69	105	71	general	treated	L
Myanmmar	15-29	Women	2	6	2	general	controlled	L
Myanmmar	30-44	Women	8	99	51	general	controlled	L
Myanmmar	45-59	Women	57	285	191	general	controlled	L
Myanmmar	60-79	Women	19	105	69	general	controlled	L
Myanmmar	all ages	Women	495	5379	5379	general	prevalence	L
Myanmmar	all ages	Women	357	5379	495	general	tested	L
Myanmmar	all ages	Women	322	5379	357	general	diagnosed	L
Myanmmar	all ages	Women	313	5379	322	general	treated	L
Myanmmar	all ages	Women	86	5379	313	general	controlled	L
Myanmmar	15-29	Men	5	299	299	general	prevalence	L
Myanmmar	30-44	Men	34	1046	1046	general	prevalence	L
Myanmmar	45-59	Men	79	1219	1219	general	prevalence	L
Myanmmar	60-79	Men	26	328	328	general	prevalence	L
Myanmmar	15-29	Men	1	5	5	general	tested	L
Myanmmar	30-44	Men	18	34	34	general	tested	L
Myanmmar	45-59	Men	55	79	79	general	tested	L
Myanmmar	60-79	Men	22	26	26	general	tested	L
Myanmmar	15-29	Men	1	5	1	general	diagnosed	L
Myanmmar	30-44	Men	18	34	18	general	diagnosed	L
Myanmmar	45-59	Men	46	79	55	general	diagnosed	L
Myanmmar	60-79	Men	18	26	22	general	diagnosed	L
Myanmmar	15-29	Men	1	5	1	general	treated	L
Myanmmar	30-44	Men	15	34	18	general	treated	L
Myanmmar	45-59	Men	44	79	46	general	treated	L
Myanmmar	60-79	Men	16	26	18	general	treated	L
Myanmmar	15-29	Men	1	5	1	general	controlled	L
Myanmmar	30-44	Men	5	34	15	general	controlled	L
Myanmmar	45-59	Men	19	79	44	general	controlled	L
Myanmmar	60-79	Men	5	26	16	general	controlled	L
Myanmmar	all ages	Men	144	2892	2892	general	prevalence	L
Myanmmar	all ages	Men	96	2892	144	general	tested	L
Myanmmar	all ages	Men	83	2892	96	general	diagnosed	L
Myanmmar	all ages	Men	76	2892	83	general	treated	L
Myanmmar	all ages	Men	30	2892	76	general	controlled	L
Nauru	15-29	Women	14	266	266	general	prevalence	LM
Nauru	30-44	Women	41	276	276	general	prevalence	LM
Nauru	45-59	Women	49	148	148	general	prevalence	LM
Nauru	60-79	Women	15	45	45	general	prevalence	LM
Nauru	15-29	Women	10	14	14	general	tested	LM
Nauru	30-44	Women	35	41	41	general	tested	LM
Nauru	45-59	Women	43	49	49	general	tested	LM
Nauru	60-79	Women	13	15	15	general	tested	LM
Nauru	15-29	Women	8	14	10	general	diagnosed	LM
Nauru	30-44	Women	31	41	35	general	diagnosed	LM
Nauru	45-59	Women	38	49	43	general	diagnosed	LM
Nauru	60-79	Women	10	15	13	general	diagnosed	LM
Nauru	15-29	Women	6	14	8	general	treated	LM
Nauru	30-44	Women	27	41	31	general	treated	LM
Nauru	45-59	Women	34	49	38	general	treated	LM
Nauru	60-79	Women	10	15	10	general	treated	LM
Nauru	15-29	Women	2	14	6	general	controlled	LM
Nauru	30-44	Women	9	41	27	general	controlled	LM
Nauru	45-59	Women	17	49	34	general	controlled	LM
Nauru	60-79	Women	6	15	10	general	controlled	LM
Nauru	all ages	Women	119	735	735	general	prevalence	LM
Nauru	all ages	Women	101	735	119	general	tested	LM
Nauru	all ages	Women	87	735	101	general	diagnosed	LM
Nauru	all ages	Women	77	735	87	general	treated	LM
Nauru	all ages	Women	34	735	77	general	controlled	LM
Nauru	15-29	Men	9	271	271	general	prevalence	LM
Nauru	30-44	Men	32	230	230	general	prevalence	LM
Nauru	45-59	Men	36	123	123	general	prevalence	LM
Nauru	60-79	Men	1	28	28	general	prevalence	LM
Nauru	15-29	Men	6	9	9	general	tested	LM
Nauru	30-44	Men	24	32	32	general	tested	LM
Nauru	45-59	Men	33	36	36	general	tested	LM
Nauru	60-79	Men	1	1	1	general	tested	LM
Nauru	15-29	Men	3	9	6	general	diagnosed	LM
Nauru	30-44	Men	17	32	24	general	diagnosed	LM
Nauru	45-59	Men	26	36	33	general	diagnosed	LM
Nauru	60-79	Men	1	1	1	general	diagnosed	LM
Nauru	15-29	Men	3	9	3	general	treated	LM
Nauru	30-44	Men	16	32	17	general	treated	LM
Nauru	45-59	Men	24	36	26	general	treated	LM
Nauru	60-79	Men	1	1	1	general	treated	LM
Nauru	15-29	Men	2	9	3	general	controlled	LM
Nauru	30-44	Men	3	32	16	general	controlled	LM
Nauru	45-59	Men	9	36	24	general	controlled	LM
Nauru	60-79	Men	1	1	1	general	controlled	LM
Nauru	all ages	Men	78	652	652	general	prevalence	LM
Nauru	all ages	Men	64	652	78	general	tested	LM
Nauru	all ages	Men	47	652	64	general	diagnosed	LM
Nauru	all ages	Men	44	652	47	general	treated	LM
Nauru	all ages	Men	15	652	44	general	controlled	LM
Nepal	15-29	Women	7	450	450	general	prevalence	L
Nepal	30-44	Women	41	636	636	general	prevalence	L
Nepal	45-59	Women	64	601	601	general	prevalence	L
Nepal	60-79	Women	31	311	311	general	prevalence	L
Nepal	15-29	Women	1	7	7	general	tested	L
Nepal	30-44	Women	12	41	41	general	tested	L
Nepal	45-59	Women	36	64	64	general	tested	L
Nepal	60-79	Women	15	31	31	general	tested	L
Nepal	15-29	Women	0	7	1	general	diagnosed	L
Nepal	30-44	Women	7	41	12	general	diagnosed	L
Nepal	45-59	Women	28	64	36	general	diagnosed	L
Nepal	60-79	Women	12	31	15	general	diagnosed	L
Nepal	15-29	Women	0	7	0	general	treated	L
Nepal	30-44	Women	6	41	7	general	treated	L
Nepal	45-59	Women	24	64	28	general	treated	L
Nepal	60-79	Women	12	31	12	general	treated	L
Nepal	15-29	Women	0	7	0	general	controlled	L
Nepal	30-44	Women	3	41	6	general	controlled	L
Nepal	45-59	Women	7	64	24	general	controlled	L
Nepal	60-79	Women	4	31	12	general	controlled	L
Nepal	all ages	Women	143	1998	1998	general	prevalence	L
Nepal	all ages	Women	64	1998	143	general	tested	L
Nepal	all ages	Women	47	1998	64	general	diagnosed	L
Nepal	all ages	Women	42	1998	47	general	treated	L
Nepal	all ages	Women	14	1998	42	general	controlled	L
Nepal	15-29	Men	23	1016	1016	general	prevalence	L
Nepal	30-44	Men	68	1403	1403	general	prevalence	L
Nepal	45-59	Men	75	795	795	general	prevalence	L
Nepal	60-79	Men	32	381	381	general	prevalence	L
Nepal	15-29	Men	1	23	23	general	tested	L
Nepal	30-44	Men	17	68	68	general	tested	L
Nepal	45-59	Men	33	75	75	general	tested	L
Nepal	60-79	Men	18	32	32	general	tested	L
Nepal	15-29	Men	0	23	1	general	diagnosed	L
Nepal	30-44	Men	10	68	17	general	diagnosed	L
Nepal	45-59	Men	24	75	33	general	diagnosed	L
Nepal	60-79	Men	12	32	18	general	diagnosed	L
Nepal	15-29	Men	0	23	0	general	treated	L
Nepal	30-44	Men	10	68	10	general	treated	L
Nepal	45-59	Men	23	75	24	general	treated	L
Nepal	60-79	Men	11	32	12	general	treated	L
Nepal	15-29	Men	0	23	0	general	controlled	L
Nepal	30-44	Men	1	68	10	general	controlled	L
Nepal	45-59	Men	8	75	23	general	controlled	L
Nepal	60-79	Men	3	32	11	general	controlled	L
Nepal	all ages	Men	198	3595	3595	general	prevalence	L
Nepal	all ages	Men	69	3595	198	general	tested	L
Nepal	all ages	Men	46	3595	69	general	diagnosed	L
Nepal	all ages	Men	44	3595	46	general	treated	L
Nepal	all ages	Men	12	3595	44	general	controlled	L
Republic of Moldova	15-29	Women	5	519	519	general	prevalence	LM
Republic of Moldova	30-44	Women	33	760	760	general	prevalence	LM
Republic of Moldova	45-59	Women	81	1010	1010	general	prevalence	LM
Republic of Moldova	60-79	Women	118	691	691	general	prevalence	LM
Republic of Moldova	15-29	Women	3	5	5	general	tested	LM
Republic of Moldova	30-44	Women	24	33	33	general	tested	LM
Republic of Moldova	45-59	Women	73	81	81	general	tested	LM
Republic of Moldova	60-79	Women	110	118	118	general	tested	LM
Republic of Moldova	15-29	Women	0	5	3	general	diagnosed	LM
Republic of Moldova	30-44	Women	8	33	24	general	diagnosed	LM
Republic of Moldova	45-59	Women	52	81	73	general	diagnosed	LM
Republic of Moldova	60-79	Women	83	118	110	general	diagnosed	LM
Republic of Moldova	15-29	Women	0	5	0	general	treated	LM
Republic of Moldova	30-44	Women	8	33	8	general	treated	LM
Republic of Moldova	45-59	Women	52	81	52	general	treated	LM
Republic of Moldova	60-79	Women	82	118	83	general	treated	LM
Republic of Moldova	15-29	Women	0	5	0	general	controlled	LM
Republic of Moldova	30-44	Women	5	33	8	general	controlled	LM
Republic of Moldova	45-59	Women	32	81	52	general	controlled	LM
Republic of Moldova	60-79	Women	50	118	82	general	controlled	LM
Republic of Moldova	all ages	Women	237	2980	2980	general	prevalence	LM
Republic of Moldova	all ages	Women	210	2980	237	general	tested	LM
Republic of Moldova	all ages	Women	143	2980	210	general	diagnosed	LM
Republic of Moldova	all ages	Women	142	2980	143	general	treated	LM
Republic of Moldova	all ages	Women	87	2980	142	general	controlled	LM
Republic of Moldova	15-29	Men	3	329	329	general	prevalence	LM
Republic of Moldova	30-44	Men	17	473	473	general	prevalence	LM
Republic of Moldova	45-59	Men	54	678	678	general	prevalence	LM
Republic of Moldova	60-79	Men	47	347	347	general	prevalence	LM
Republic of Moldova	15-29	Men	3	3	3	general	tested	LM
Republic of Moldova	30-44	Men	11	17	17	general	tested	LM
Republic of Moldova	45-59	Men	39	54	54	general	tested	LM
Republic of Moldova	60-79	Men	42	47	47	general	tested	LM
Republic of Moldova	15-29	Men	0	3	3	general	diagnosed	LM
Republic of Moldova	30-44	Men	7	17	11	general	diagnosed	LM
Republic of Moldova	45-59	Men	24	54	39	general	diagnosed	LM
Republic of Moldova	60-79	Men	30	47	42	general	diagnosed	LM
Republic of Moldova	15-29	Men	0	3	0	general	treated	LM
Republic of Moldova	30-44	Men	6	17	7	general	treated	LM
Republic of Moldova	45-59	Men	23	54	24	general	treated	LM
Republic of Moldova	60-79	Men	29	47	30	general	treated	LM
Republic of Moldova	15-29	Men	0	3	0	general	controlled	LM
Republic of Moldova	30-44	Men	3	17	6	general	controlled	LM
Republic of Moldova	45-59	Men	10	54	23	general	controlled	LM
Republic of Moldova	60-79	Men	15	47	29	general	controlled	LM
Republic of Moldova	all ages	Men	121	1827	1827	general	prevalence	LM
Republic of Moldova	all ages	Men	95	1827	121	general	tested	LM
Republic of Moldova	all ages	Men	61	1827	95	general	diagnosed	LM
Republic of Moldova	all ages	Men	58	1827	61	general	treated	LM
Republic of Moldova	all ages	Men	28	1827	58	general	controlled	LM
Sao Tome	15-29	Women	19	449	449	general	prevalence	L
Sao Tome	30-44	Women	40	571	571	general	prevalence	L
Sao Tome	45-59	Women	43	311	311	general	prevalence	L
Sao Tome	60-79	Women	23	108	108	general	prevalence	L
Sao Tome	15-29	Women	12	19	19	general	tested	L
Sao Tome	30-44	Women	12	40	40	general	tested	L
Sao Tome	45-59	Women	23	43	43	general	tested	L
Sao Tome	60-79	Women	18	23	23	general	tested	L
Sao Tome	15-29	Women	3	19	12	general	diagnosed	L
Sao Tome	30-44	Women	3	40	12	general	diagnosed	L
Sao Tome	45-59	Women	15	43	23	general	diagnosed	L
Sao Tome	60-79	Women	12	23	18	general	diagnosed	L
Sao Tome	15-29	Women	3	19	3	general	treated	L
Sao Tome	30-44	Women	3	40	3	general	treated	L
Sao Tome	45-59	Women	13	43	15	general	treated	L
Sao Tome	60-79	Women	10	23	12	general	treated	L
Sao Tome	15-29	Women	3	19	3	general	controlled	L
Sao Tome	30-44	Women	3	40	3	general	controlled	L
Sao Tome	45-59	Women	6	43	13	general	controlled	L
Sao Tome	60-79	Women	6	23	10	general	controlled	L
Sao Tome	all ages	Women	125	1439	1439	general	prevalence	L
Sao Tome	all ages	Women	65	1439	125	general	tested	L
Sao Tome	all ages	Women	33	1439	65	general	diagnosed	L
Sao Tome	all ages	Women	29	1439	33	general	treated	L
Sao Tome	all ages	Women	18	1439	29	general	controlled	L
Sao Tome	15-29	Men	21	330	330	general	prevalence	L
Sao Tome	30-44	Men	32	386	386	general	prevalence	L
Sao Tome	45-59	Men	20	187	187	general	prevalence	L
Sao Tome	60-79	Men	7	76	76	general	prevalence	L
Sao Tome	15-29	Men	2	21	21	general	tested	L
Sao Tome	30-44	Men	14	32	32	general	tested	L
Sao Tome	45-59	Men	11	20	20	general	tested	L
Sao Tome	60-79	Men	5	7	7	general	tested	L
Sao Tome	15-29	Men	0	21	2	general	diagnosed	L
Sao Tome	30-44	Men	7	32	14	general	diagnosed	L
Sao Tome	45-59	Men	8	20	11	general	diagnosed	L
Sao Tome	60-79	Men	3	7	5	general	diagnosed	L
Sao Tome	15-29	Men	0	21	0	general	treated	L
Sao Tome	30-44	Men	6	32	7	general	treated	L
Sao Tome	45-59	Men	6	20	8	general	treated	L
Sao Tome	60-79	Men	3	7	3	general	treated	L
Sao Tome	15-29	Men	0	21	0	general	controlled	L
Sao Tome	30-44	Men	2	32	6	general	controlled	L
Sao Tome	45-59	Men	1	20	6	general	controlled	L
Sao Tome	60-79	Men	2	7	3	general	controlled	L
Sao Tome	all ages	Men	80	979	979	general	prevalence	L
Sao Tome	all ages	Men	32	979	80	general	tested	L
Sao Tome	all ages	Men	18	979	32	general	diagnosed	L
Sao Tome	all ages	Men	15	979	18	general	treated	L
Sao Tome	all ages	Men	5	979	15	general	controlled	L
Solomon Islands 	15-29	Women	8	372	372	general	prevalence	L
Solomon Islands 	30-44	Women	16	614	614	general	prevalence	L
Solomon Islands 	45-59	Women	28	298	298	general	prevalence	L
Solomon Islands 	60-79	Women	11	118	118	general	prevalence	L
Solomon Islands 	15-29	Women	1	8	8	general	tested	L
Solomon Islands 	30-44	Women	5	16	16	general	tested	L
Solomon Islands 	45-59	Women	13	28	28	general	tested	L
Solomon Islands 	60-79	Women	7	11	11	general	tested	L
Solomon Islands 	15-29	Women	0	8	1	general	diagnosed	L
Solomon Islands 	30-44	Women	2	16	5	general	diagnosed	L
Solomon Islands 	45-59	Women	7	28	13	general	diagnosed	L
Solomon Islands 	60-79	Women	6	11	7	general	diagnosed	L
Solomon Islands 	15-29	Women	0	8	0	general	treated	L
Solomon Islands 	30-44	Women	2	16	2	general	treated	L
Solomon Islands 	45-59	Women	6	28	7	general	treated	L
Solomon Islands 	60-79	Women	5	11	6	general	treated	L
Solomon Islands 	15-29	Women	0	8	0	general	controlled	L
Solomon Islands 	30-44	Women	1	16	2	general	controlled	L
Solomon Islands 	45-59	Women	3	28	6	general	controlled	L
Solomon Islands 	60-79	Women	1	11	5	general	controlled	L
Solomon Islands 	all ages	Women	63	1402	1402	general	prevalence	L
Solomon Islands 	all ages	Women	26	1402	63	general	tested	L
Solomon Islands 	all ages	Women	15	1402	26	general	diagnosed	L
Solomon Islands 	all ages	Women	13	1402	15	general	treated	L
Solomon Islands 	all ages	Women	5	1402	13	general	controlled	L
Solomon Islands 	15-29	Men	5	285	285	general	prevalence	L
Solomon Islands 	30-44	Men	10	408	408	general	prevalence	L
Solomon Islands 	45-59	Men	27	314	314	general	prevalence	L
Solomon Islands 	60-79	Men	7	124	124	general	prevalence	L
Solomon Islands 	15-29	Men	3	5	5	general	tested	L
Solomon Islands 	30-44	Men	3	10	10	general	tested	L
Solomon Islands 	45-59	Men	13	27	27	general	tested	L
Solomon Islands 	60-79	Men	5	7	7	general	tested	L
Solomon Islands 	15-29	Men	3	5	3	general	diagnosed	L
Solomon Islands 	30-44	Men	1	10	3	general	diagnosed	L
Solomon Islands 	45-59	Men	5	27	13	general	diagnosed	L
Solomon Islands 	60-79	Men	3	7	5	general	diagnosed	L
Solomon Islands 	15-29	Men	3	5	3	general	treated	L
Solomon Islands 	30-44	Men	1	10	1	general	treated	L
Solomon Islands 	45-59	Men	5	27	5	general	treated	L
Solomon Islands 	60-79	Men	2	7	3	general	treated	L
Solomon Islands 	15-29	Men	2	5	3	general	controlled	L
Solomon Islands 	30-44	Men	0	10	1	general	controlled	L
Solomon Islands 	45-59	Men	1	27	5	general	controlled	L
Solomon Islands 	60-79	Men	0	7	2	general	controlled	L
Solomon Islands 	all ages	Men	49	1131	1131	general	prevalence	L
Solomon Islands 	all ages	Men	24	1131	49	general	tested	L
Solomon Islands 	all ages	Men	12	1131	24	general	diagnosed	L
Solomon Islands 	all ages	Men	11	1131	12	general	treated	L
Solomon Islands 	all ages	Men	3	1131	11	general	controlled	L
Sri Lanka	15-29	Women	9	508	508	general	prevalence	UM
Sri Lanka	30-44	Women	72	1143	1143	general	prevalence	UM
Sri Lanka	45-59	Women	163	1004	1004	general	prevalence	UM
Sri Lanka	60-79	Women	138	503	503	general	prevalence	UM
Sri Lanka	15-29	Women	5	9	9	general	tested	UM
Sri Lanka	30-44	Women	60	72	72	general	tested	UM
Sri Lanka	45-59	Women	147	163	163	general	tested	UM
Sri Lanka	60-79	Women	130	138	138	general	tested	UM
Sri Lanka	15-29	Women	1	9	5	general	diagnosed	UM
Sri Lanka	30-44	Women	44	72	60	general	diagnosed	UM
Sri Lanka	45-59	Women	131	163	147	general	diagnosed	UM
Sri Lanka	60-79	Women	118	138	130	general	diagnosed	UM
Sri Lanka	15-29	Women	1	9	1	general	treated	UM
Sri Lanka	30-44	Women	44	72	44	general	treated	UM
Sri Lanka	45-59	Women	131	163	131	general	treated	UM
Sri Lanka	60-79	Women	117	138	118	general	treated	UM
Sri Lanka	15-29	Women	0	9	1	general	controlled	UM
Sri Lanka	30-44	Women	23	72	44	general	controlled	UM
Sri Lanka	45-59	Women	64	163	131	general	controlled	UM
Sri Lanka	60-79	Women	63	138	117	general	controlled	UM
Sri Lanka	all ages	Women	382	3158	3158	general	prevalence	UM
Sri Lanka	all ages	Women	342	3158	382	general	tested	UM
Sri Lanka	all ages	Women	294	3158	342	general	diagnosed	UM
Sri Lanka	all ages	Women	293	3158	294	general	treated	UM
Sri Lanka	all ages	Women	150	3158	293	general	controlled	UM
Sri Lanka	15-29	Men	7	295	295	general	prevalence	UM
Sri Lanka	30-44	Men	49	679	679	general	prevalence	UM
Sri Lanka	45-59	Men	108	691	691	general	prevalence	UM
Sri Lanka	60-79	Men	61	365	365	general	prevalence	UM
Sri Lanka	15-29	Men	4	7	7	general	tested	UM
Sri Lanka	30-44	Men	41	49	49	general	tested	UM
Sri Lanka	45-59	Men	98	108	108	general	tested	UM
Sri Lanka	60-79	Men	58	61	61	general	tested	UM
Sri Lanka	15-29	Men	2	7	4	general	diagnosed	UM
Sri Lanka	30-44	Men	34	49	41	general	diagnosed	UM
Sri Lanka	45-59	Men	82	108	98	general	diagnosed	UM
Sri Lanka	60-79	Men	50	61	58	general	diagnosed	UM
Sri Lanka	15-29	Men	1	7	2	general	treated	UM
Sri Lanka	30-44	Men	34	49	34	general	treated	UM
Sri Lanka	45-59	Men	75	108	82	general	treated	UM
Sri Lanka	60-79	Men	50	61	50	general	treated	UM
Sri Lanka	15-29	Men	1	7	1	general	controlled	UM
Sri Lanka	30-44	Men	18	49	34	general	controlled	UM
Sri Lanka	45-59	Men	40	108	75	general	controlled	UM
Sri Lanka	60-79	Men	31	61	50	general	controlled	UM
Sri Lanka	all ages	Men	225	2030	2030	general	prevalence	UM
Sri Lanka	all ages	Men	201	2030	225	general	tested	UM
Sri Lanka	all ages	Men	168	2030	201	general	diagnosed	UM
Sri Lanka	all ages	Men	160	2030	168	general	treated	UM
Sri Lanka	all ages	Men	90	2030	160	general	controlled	UM
Sudan	15-29	Women	52	1689	1689	general	prevalence	L
Sudan	30-44	Women	131	1921	1921	general	prevalence	L
Sudan	45-59	Women	177	1032	1032	general	prevalence	L
Sudan	60-79	Women	65	373	373	general	prevalence	L
Sudan	15-29	Women	14	52	52	general	tested	L
Sudan	30-44	Women	67	131	131	general	tested	L
Sudan	45-59	Women	128	177	177	general	tested	L
Sudan	60-79	Women	51	65	65	general	tested	L
Sudan	15-29	Women	11	52	14	general	diagnosed	L
Sudan	30-44	Women	44	131	67	general	diagnosed	L
Sudan	45-59	Women	107	177	128	general	diagnosed	L
Sudan	60-79	Women	46	65	51	general	diagnosed	L
Sudan	15-29	Women	10	52	11	general	treated	L
Sudan	30-44	Women	42	131	44	general	treated	L
Sudan	45-59	Women	102	177	107	general	treated	L
Sudan	60-79	Women	44	65	46	general	treated	L
Sudan	15-29	Women	5	52	10	general	controlled	L
Sudan	30-44	Women	16	131	42	general	controlled	L
Sudan	45-59	Women	36	177	102	general	controlled	L
Sudan	60-79	Women	25	65	44	general	controlled	L
Sudan	all ages	Women	425	5015	5015	general	prevalence	L
Sudan	all ages	Women	260	5015	425	general	tested	L
Sudan	all ages	Women	208	5015	260	general	diagnosed	L
Sudan	all ages	Women	198	5015	208	general	treated	L
Sudan	all ages	Women	82	5015	198	general	controlled	L
Sudan	15-29	Men	23	721	721	general	prevalence	L
Sudan	30-44	Men	51	894	894	general	prevalence	L
Sudan	45-59	Men	116	727	727	general	prevalence	L
Sudan	60-79	Men	45	365	365	general	prevalence	L
Sudan	15-29	Men	2	23	23	general	tested	L
Sudan	30-44	Men	23	51	51	general	tested	L
Sudan	45-59	Men	83	116	116	general	tested	L
Sudan	60-79	Men	36	45	45	general	tested	L
Sudan	15-29	Men	1	23	2	general	diagnosed	L
Sudan	30-44	Men	21	51	23	general	diagnosed	L
Sudan	45-59	Men	72	116	83	general	diagnosed	L
Sudan	60-79	Men	33	45	36	general	diagnosed	L
Sudan	15-29	Men	1	23	1	general	treated	L
Sudan	30-44	Men	18	51	21	general	treated	L
Sudan	45-59	Men	70	116	72	general	treated	L
Sudan	60-79	Men	33	45	33	general	treated	L
Sudan	15-29	Men	1	23	1	general	controlled	L
Sudan	30-44	Men	11	51	18	general	controlled	L
Sudan	45-59	Men	25	116	70	general	controlled	L
Sudan	60-79	Men	20	45	33	general	controlled	L
Sudan	all ages	Men	235	2707	2707	general	prevalence	L
Sudan	all ages	Men	144	2707	235	general	tested	L
Sudan	all ages	Men	127	2707	144	general	diagnosed	L
Sudan	all ages	Men	122	2707	127	general	treated	L
Sudan	all ages	Men	57	2707	122	general	controlled	L
Tajikistan	15-29	Women	6	432	432	general	prevalence	LM
Tajikistan	30-44	Women	30	615	615	general	prevalence	LM
Tajikistan	45-59	Women	63	436	436	general	prevalence	LM
Tajikistan	60-79	Women	24	135	135	general	prevalence	LM
Tajikistan	15-29	Women	2	6	6	general	tested	LM
Tajikistan	30-44	Women	6	30	30	general	tested	LM
Tajikistan	45-59	Women	38	63	63	general	tested	LM
Tajikistan	60-79	Women	17	24	24	general	tested	LM
Tajikistan	15-29	Women	1	6	2	general	diagnosed	LM
Tajikistan	30-44	Women	2	30	6	general	diagnosed	LM
Tajikistan	45-59	Women	21	63	38	general	diagnosed	LM
Tajikistan	60-79	Women	11	24	17	general	diagnosed	LM
Tajikistan	15-29	Women	1	6	1	general	treated	LM
Tajikistan	30-44	Women	2	30	2	general	treated	LM
Tajikistan	45-59	Women	20	63	21	general	treated	LM
Tajikistan	60-79	Women	9	24	11	general	treated	LM
Tajikistan	15-29	Women	1	6	1	general	controlled	LM
Tajikistan	30-44	Women	2	30	2	general	controlled	LM
Tajikistan	45-59	Women	7	63	20	general	controlled	LM
Tajikistan	60-79	Women	4	24	9	general	controlled	LM
Tajikistan	all ages	Women	123	1618	1618	general	prevalence	LM
Tajikistan	all ages	Women	63	1618	123	general	tested	LM
Tajikistan	all ages	Women	35	1618	63	general	diagnosed	LM
Tajikistan	all ages	Women	32	1618	35	general	treated	LM
Tajikistan	all ages	Women	14	1618	32	general	controlled	LM
Tajikistan	15-29	Men	11	312	312	general	prevalence	LM
Tajikistan	30-44	Men	25	347	347	general	prevalence	LM
Tajikistan	45-59	Men	37	336	336	general	prevalence	LM
Tajikistan	60-79	Men	17	104	104	general	prevalence	LM
Tajikistan	15-29	Men	1	11	11	general	tested	LM
Tajikistan	30-44	Men	7	25	25	general	tested	LM
Tajikistan	45-59	Men	19	37	37	general	tested	LM
Tajikistan	60-79	Men	10	17	17	general	tested	LM
Tajikistan	15-29	Men	0	11	1	general	diagnosed	LM
Tajikistan	30-44	Men	3	25	7	general	diagnosed	LM
Tajikistan	45-59	Men	12	37	19	general	diagnosed	LM
Tajikistan	60-79	Men	8	17	10	general	diagnosed	LM
Tajikistan	15-29	Men	0	11	0	general	treated	LM
Tajikistan	30-44	Men	3	25	3	general	treated	LM
Tajikistan	45-59	Men	12	37	12	general	treated	LM
Tajikistan	60-79	Men	6	17	8	general	treated	LM
Tajikistan	15-29	Men	0	11	0	general	controlled	LM
Tajikistan	30-44	Men	1	25	3	general	controlled	LM
Tajikistan	45-59	Men	7	37	12	general	controlled	LM
Tajikistan	60-79	Men	4	17	6	general	controlled	LM
Tajikistan	all ages	Men	90	1100	1100	general	prevalence	LM
Tajikistan	all ages	Men	37	1100	90	general	tested	LM
Tajikistan	all ages	Men	23	1100	37	general	diagnosed	LM
Tajikistan	all ages	Men	21	1100	23	general	treated	LM
Tajikistan	all ages	Men	12	1100	21	general	controlled	LM
Timor Leste	15-29	Women	1	447	447	general	prevalence	L
Timor Leste	30-44	Women	20	575	575	general	prevalence	L
Timor Leste	45-59	Women	11	313	313	general	prevalence	L
Timor Leste	60-79	Women	5	191	191	general	prevalence	L
Timor Leste	15-29	Women	0	1	1	general	tested	L
Timor Leste	30-44	Women	3	20	20	general	tested	L
Timor Leste	45-59	Women	2	11	11	general	tested	L
Timor Leste	60-79	Women	1	5	5	general	tested	L
Timor Leste	15-29	Women	0	1	0	general	diagnosed	L
Timor Leste	30-44	Women	1	20	3	general	diagnosed	L
Timor Leste	45-59	Women	2	11	2	general	diagnosed	L
Timor Leste	60-79	Women	1	5	1	general	diagnosed	L
Timor Leste	15-29	Women	0	1	0	general	treated	L
Timor Leste	30-44	Women	1	20	1	general	treated	L
Timor Leste	45-59	Women	2	11	2	general	treated	L
Timor Leste	60-79	Women	0	5	1	general	treated	L
Timor Leste	15-29	Women	0	1	0	general	controlled	L
Timor Leste	30-44	Women	1	20	1	general	controlled	L
Timor Leste	45-59	Women	0	11	2	general	controlled	L
Timor Leste	60-79	Women	0	5	0	general	controlled	L
Timor Leste	all ages	Women	37	1526	1526	general	prevalence	L
Timor Leste	all ages	Women	6	1526	37	general	tested	L
Timor Leste	all ages	Women	4	1526	6	general	diagnosed	L
Timor Leste	all ages	Women	3	1526	4	general	treated	L
Timor Leste	all ages	Women	1	1526	3	general	controlled	L
Timor Leste	15-29	Men	4	226	226	general	prevalence	L
Timor Leste	30-44	Men	7	376	376	general	prevalence	L
Timor Leste	45-59	Men	12	283	283	general	prevalence	L
Timor Leste	60-79	Men	10	198	198	general	prevalence	L
Timor Leste	15-29	Men	0	4	4	general	tested	L
Timor Leste	30-44	Men	1	7	7	general	tested	L
Timor Leste	45-59	Men	3	12	12	general	tested	L
Timor Leste	60-79	Men	2	10	10	general	tested	L
Timor Leste	15-29	Men	0	4	0	general	diagnosed	L
Timor Leste	30-44	Men	1	7	1	general	diagnosed	L
Timor Leste	45-59	Men	3	12	3	general	diagnosed	L
Timor Leste	60-79	Men	2	10	2	general	diagnosed	L
Timor Leste	15-29	Men	0	4	0	general	treated	L
Timor Leste	30-44	Men	1	7	1	general	treated	L
Timor Leste	45-59	Men	3	12	3	general	treated	L
Timor Leste	60-79	Men	2	10	2	general	treated	L
Timor Leste	15-29	Men	0	4	0	general	controlled	L
Timor Leste	30-44	Men	1	7	1	general	controlled	L
Timor Leste	45-59	Men	0	12	3	general	controlled	L
Timor Leste	60-79	Men	1	10	2	general	controlled	L
Timor Leste	all ages	Men	33	1083	1083	general	prevalence	L
Timor Leste	all ages	Men	6	1083	33	general	tested	L
Timor Leste	all ages	Men	6	1083	6	general	diagnosed	L
Timor Leste	all ages	Men	6	1083	6	general	treated	L
Timor Leste	all ages	Men	2	1083	6	general	controlled	L
Turkemenistan	15-29	Women	12	586	586	general	prevalence	LM
Turkemenistan	30-44	Women	41	866	866	general	prevalence	LM
Turkemenistan	45-59	Women	61	658	658	general	prevalence	LM
Turkemenistan	60-79	Women	47	227	227	general	prevalence	LM
Turkemenistan	15-29	Women	4	12	12	general	tested	LM
Turkemenistan	30-44	Women	18	41	41	general	tested	LM
Turkemenistan	45-59	Women	45	61	61	general	tested	LM
Turkemenistan	60-79	Women	40	47	47	general	tested	LM
Turkemenistan	15-29	Women	0	12	4	general	diagnosed	LM
Turkemenistan	30-44	Women	7	41	18	general	diagnosed	LM
Turkemenistan	45-59	Women	16	61	45	general	diagnosed	LM
Turkemenistan	60-79	Women	21	47	40	general	diagnosed	LM
Turkemenistan	15-29	Women	0	12	0	general	treated	LM
Turkemenistan	30-44	Women	7	41	7	general	treated	LM
Turkemenistan	45-59	Women	14	61	16	general	treated	LM
Turkemenistan	60-79	Women	21	47	21	general	treated	LM
Turkemenistan	15-29	Women	0	12	0	general	controlled	LM
Turkemenistan	30-44	Women	4	41	7	general	controlled	LM
Turkemenistan	45-59	Women	6	61	14	general	controlled	LM
Turkemenistan	60-79	Women	13	47	21	general	controlled	LM
Turkemenistan	all ages	Women	161	2337	2337	general	prevalence	LM
Turkemenistan	all ages	Women	107	2337	161	general	tested	LM
Turkemenistan	all ages	Women	44	2337	107	general	diagnosed	LM
Turkemenistan	all ages	Women	42	2337	44	general	treated	LM
Turkemenistan	all ages	Women	23	2337	42	general	controlled	LM
Turkemenistan	15-29	Men	13	430	430	general	prevalence	LM
Turkemenistan	30-44	Men	36	669	669	general	prevalence	LM
Turkemenistan	45-59	Men	43	460	460	general	prevalence	LM
Turkemenistan	60-79	Men	19	157	157	general	prevalence	LM
Turkemenistan	15-29	Men	1	13	13	general	tested	LM
Turkemenistan	30-44	Men	10	36	36	general	tested	LM
Turkemenistan	45-59	Men	29	43	43	general	tested	LM
Turkemenistan	60-79	Men	14	19	19	general	tested	LM
Turkemenistan	15-29	Men	0	13	1	general	diagnosed	LM
Turkemenistan	30-44	Men	4	36	10	general	diagnosed	LM
Turkemenistan	45-59	Men	12	43	29	general	diagnosed	LM
Turkemenistan	60-79	Men	7	19	14	general	diagnosed	LM
Turkemenistan	15-29	Men	0	13	0	general	treated	LM
Turkemenistan	30-44	Men	4	36	4	general	treated	LM
Turkemenistan	45-59	Men	12	43	12	general	treated	LM
Turkemenistan	60-79	Men	7	19	7	general	treated	LM
Turkemenistan	15-29	Men	0	13	0	general	controlled	LM
Turkemenistan	30-44	Men	3	36	4	general	controlled	LM
Turkemenistan	45-59	Men	6	43	12	general	controlled	LM
Turkemenistan	60-79	Men	2	19	7	general	controlled	LM
Turkemenistan	all ages	Men	111	1716	1716	general	prevalence	LM
Turkemenistan	all ages	Men	54	1716	111	general	tested	LM
Turkemenistan	all ages	Men	23	1716	54	general	diagnosed	LM
Turkemenistan	all ages	Men	23	1716	23	general	treated	LM
Turkemenistan	all ages	Men	11	1716	23	general	controlled	LM
Tuvalu	15-29	Women	1	155	155	general	prevalence	L
Tuvalu	30-44	Women	20	180	180	general	prevalence	L
Tuvalu	45-59	Women	48	209	209	general	prevalence	L
Tuvalu	60-79	Women	14	84	84	general	prevalence	L
Tuvalu	15-29	Women	1	1	1	general	tested	L
Tuvalu	30-44	Women	15	20	20	general	tested	L
Tuvalu	45-59	Women	36	48	48	general	tested	L
Tuvalu	60-79	Women	11	14	14	general	tested	L
Tuvalu	15-29	Women	1	1	1	general	diagnosed	L
Tuvalu	30-44	Women	11	20	15	general	diagnosed	L
Tuvalu	45-59	Women	29	48	36	general	diagnosed	L
Tuvalu	60-79	Women	9	14	11	general	diagnosed	L
Tuvalu	15-29	Women	1	1	1	general	treated	L
Tuvalu	30-44	Women	11	20	11	general	treated	L
Tuvalu	45-59	Women	29	48	29	general	treated	L
Tuvalu	60-79	Women	9	14	9	general	treated	L
Tuvalu	15-29	Women	1	1	1	general	controlled	L
Tuvalu	30-44	Women	3	20	11	general	controlled	L
Tuvalu	45-59	Women	14	48	29	general	controlled	L
Tuvalu	60-79	Women	8	14	9	general	controlled	L
Tuvalu	all ages	Women	83	628	628	general	prevalence	L
Tuvalu	all ages	Women	63	628	83	general	tested	L
Tuvalu	all ages	Women	50	628	63	general	diagnosed	L
Tuvalu	all ages	Women	50	628	50	general	treated	L
Tuvalu	all ages	Women	26	628	50	general	controlled	L
Tuvalu	15-29	Men	2	152	152	general	prevalence	L
Tuvalu	30-44	Men	9	149	149	general	prevalence	L
Tuvalu	45-59	Men	24	173	173	general	prevalence	L
Tuvalu	60-79	Men	9	53	53	general	prevalence	L
Tuvalu	15-29	Men	0	2	2	general	tested	L
Tuvalu	30-44	Men	6	9	9	general	tested	L
Tuvalu	45-59	Men	18	24	24	general	tested	L
Tuvalu	60-79	Men	7	9	9	general	tested	L
Tuvalu	15-29	Men	0	2	0	general	diagnosed	L
Tuvalu	30-44	Men	2	9	6	general	diagnosed	L
Tuvalu	45-59	Men	14	24	18	general	diagnosed	L
Tuvalu	60-79	Men	4	9	7	general	diagnosed	L
Tuvalu	15-29	Men	0	2	0	general	treated	L
Tuvalu	30-44	Men	2	9	2	general	treated	L
Tuvalu	45-59	Men	14	24	14	general	treated	L
Tuvalu	60-79	Men	3	9	4	general	treated	L
Tuvalu	15-29	Men	0	2	0	general	controlled	L
Tuvalu	30-44	Men	0	9	2	general	controlled	L
Tuvalu	45-59	Men	6	24	14	general	controlled	L
Tuvalu	60-79	Men	2	9	3	general	controlled	L
Tuvalu	all ages	Men	44	527	527	general	prevalence	L
Tuvalu	all ages	Men	31	527	44	general	tested	L
Tuvalu	all ages	Men	20	527	31	general	diagnosed	L
Tuvalu	all ages	Men	19	527	20	general	treated	L
Tuvalu	all ages	Men	8	527	19	general	controlled	L
Uganda	15-29	Women	2	956	956	general	prevalence	L
Uganda	30-44	Women	7	824	824	general	prevalence	L
Uganda	45-59	Women	13	419	419	general	prevalence	L
Uganda	60-79	Women	5	184	184	general	prevalence	L
Uganda	15-29	Women	0	2	2	general	tested	L
Uganda	30-44	Women	4	7	7	general	tested	L
Uganda	45-59	Women	11	13	13	general	tested	L
Uganda	60-79	Women	3	5	5	general	tested	L
Uganda	15-29	Women	0	2	0	general	diagnosed	L
Uganda	30-44	Women	2	7	4	general	diagnosed	L
Uganda	45-59	Women	9	13	11	general	diagnosed	L
Uganda	60-79	Women	3	5	3	general	diagnosed	L
Uganda	15-29	Women	0	2	0	general	treated	L
Uganda	30-44	Women	2	7	2	general	treated	L
Uganda	45-59	Women	9	13	9	general	treated	L
Uganda	60-79	Women	3	5	3	general	treated	L
Uganda	15-29	Women	0	2	0	general	controlled	L
Uganda	30-44	Women	1	7	2	general	controlled	L
Uganda	45-59	Women	7	13	9	general	controlled	L
Uganda	60-79	Women	2	5	3	general	controlled	L
Uganda	all ages	Women	27	2383	2383	general	prevalence	L
Uganda	all ages	Women	18	2383	27	general	tested	L
Uganda	all ages	Women	14	2383	18	general	diagnosed	L
Uganda	all ages	Women	14	2383	14	general	treated	L
Uganda	all ages	Women	10	2383	14	general	controlled	L
Uganda	15-29	Men	3	660	660	general	prevalence	L
Uganda	30-44	Men	11	575	575	general	prevalence	L
Uganda	45-59	Men	7	280	280	general	prevalence	L
Uganda	60-79	Men	2	89	89	general	prevalence	L
Uganda	15-29	Men	1	3	3	general	tested	L
Uganda	30-44	Men	2	11	11	general	tested	L
Uganda	45-59	Men	3	7	7	general	tested	L
Uganda	60-79	Men	2	2	2	general	tested	L
Uganda	15-29	Men	1	3	1	general	diagnosed	L
Uganda	30-44	Men	2	11	2	general	diagnosed	L
Uganda	45-59	Men	2	7	3	general	diagnosed	L
Uganda	60-79	Men	2	2	2	general	diagnosed	L
Uganda	15-29	Men	1	3	1	general	treated	L
Uganda	30-44	Men	2	11	2	general	treated	L
Uganda	45-59	Men	2	7	2	general	treated	L
Uganda	60-79	Men	2	2	2	general	treated	L
Uganda	15-29	Men	1	3	1	general	controlled	L
Uganda	30-44	Men	1	11	2	general	controlled	L
Uganda	45-59	Men	1	7	2	general	controlled	L
Uganda	60-79	Men	2	2	2	general	controlled	L
Uganda	all ages	Men	23	1604	1604	general	prevalence	L
Uganda	all ages	Men	8	1604	23	general	tested	L
Uganda	all ages	Men	7	1604	8	general	diagnosed	L
Uganda	all ages	Men	7	1604	7	general	treated	L
Uganda	all ages	Men	5	1604	7	general	controlled	L
Vietnam	15-29	Women	1	375	375	general	prevalence	LM
Vietnam	30-44	Women	19	787	787	general	prevalence	LM
Vietnam	45-59	Women	33	666	666	general	prevalence	LM
Vietnam	60-79	Women	25	254	254	general	prevalence	LM
Vietnam	15-29	Women	1	1	1	general	tested	LM
Vietnam	30-44	Women	8	19	19	general	tested	LM
Vietnam	45-59	Women	22	33	33	general	tested	LM
Vietnam	60-79	Women	22	25	25	general	tested	LM
Vietnam	15-29	Women	1	1	1	general	diagnosed	LM
Vietnam	30-44	Women	4	19	8	general	diagnosed	LM
Vietnam	45-59	Women	17	33	22	general	diagnosed	LM
Vietnam	60-79	Women	22	25	22	general	diagnosed	LM
Vietnam	15-29	Women	1	1	1	general	treated	LM
Vietnam	30-44	Women	4	19	4	general	treated	LM
Vietnam	45-59	Women	17	33	17	general	treated	LM
Vietnam	60-79	Women	22	25	22	general	treated	LM
Vietnam	15-29	Women	0	1	1	general	controlled	LM
Vietnam	30-44	Women	4	19	4	general	controlled	LM
Vietnam	45-59	Women	15	33	17	general	controlled	LM
Vietnam	60-79	Women	17	25	22	general	controlled	LM
Vietnam	all ages	Women	78	2082	2082	general	prevalence	LM
Vietnam	all ages	Women	53	2082	78	general	tested	LM
Vietnam	all ages	Women	44	2082	53	general	diagnosed	LM
Vietnam	all ages	Women	44	2082	44	general	treated	LM
Vietnam	all ages	Women	36	2082	44	general	controlled	LM
Vietnam	15-29	Men	2	316	316	general	prevalence	LM
Vietnam	30-44	Men	7	587	587	general	prevalence	LM
Vietnam	45-59	Men	27	553	553	general	prevalence	LM
Vietnam	60-79	Men	13	220	220	general	prevalence	LM
Vietnam	15-29	Men	1	2	2	general	tested	LM
Vietnam	30-44	Men	5	7	7	general	tested	LM
Vietnam	45-59	Men	18	27	27	general	tested	LM
Vietnam	60-79	Men	10	13	13	general	tested	LM
Vietnam	15-29	Men	1	2	1	general	diagnosed	LM
Vietnam	30-44	Men	2	7	5	general	diagnosed	LM
Vietnam	45-59	Men	15	27	18	general	diagnosed	LM
Vietnam	60-79	Men	9	13	10	general	diagnosed	LM
Vietnam	15-29	Men	1	2	1	general	treated	LM
Vietnam	30-44	Men	2	7	2	general	treated	LM
Vietnam	45-59	Men	15	27	15	general	treated	LM
Vietnam	60-79	Men	8	13	9	general	treated	LM
Vietnam	15-29	Men	1	2	1	general	controlled	LM
Vietnam	30-44	Men	2	7	2	general	controlled	LM
Vietnam	45-59	Men	12	27	15	general	controlled	LM
Vietnam	60-79	Men	7	13	8	general	controlled	LM
Vietnam	all ages	Men	49	1676	1676	general	prevalence	LM
Vietnam	all ages	Men	34	1676	49	general	tested	LM
Vietnam	all ages	Men	27	1676	34	general	diagnosed	LM
Vietnam	all ages	Men	26	1676	27	general	treated	LM
Vietnam	all ages	Men	22	1676	26	general	controlled	LM
Zambia	15-29	Women	43	1023	1023	general	prevalence	L
Zambia	30-44	Women	66	935	935	general	prevalence	L
Zambia	45-59	Women	46	473	473	general	prevalence	L
Zambia	60-79	Women	45	257	257	general	prevalence	L
Zambia	15-29	Women	5	43	43	general	tested	L
Zambia	30-44	Women	5	66	66	general	tested	L
Zambia	45-59	Women	12	46	46	general	tested	L
Zambia	60-79	Women	13	45	45	general	tested	L
Zambia	15-29	Women	2	43	5	general	diagnosed	L
Zambia	30-44	Women	2	66	5	general	diagnosed	L
Zambia	45-59	Women	8	46	12	general	diagnosed	L
Zambia	60-79	Women	10	45	13	general	diagnosed	L
Zambia	15-29	Women	2	43	2	general	treated	L
Zambia	30-44	Women	2	66	2	general	treated	L
Zambia	45-59	Women	7	46	8	general	treated	L
Zambia	60-79	Women	9	45	10	general	treated	L
Zambia	15-29	Women	0	43	2	general	controlled	L
Zambia	30-44	Women	2	66	2	general	controlled	L
Zambia	45-59	Women	2	46	7	general	controlled	L
Zambia	60-79	Women	6	45	9	general	controlled	L
Zambia	all ages	Women	200	2688	2688	general	prevalence	L
Zambia	all ages	Women	35	2688	200	general	tested	L
Zambia	all ages	Women	22	2688	35	general	diagnosed	L
Zambia	all ages	Women	20	2688	22	general	treated	L
Zambia	all ages	Women	10	2688	20	general	controlled	L
Zambia	15-29	Men	20	597	597	general	prevalence	L
Zambia	30-44	Men	45	578	578	general	prevalence	L
Zambia	45-59	Men	37	312	312	general	prevalence	L
Zambia	60-79	Men	20	127	127	general	prevalence	L
Zambia	15-29	Men	2	20	20	general	tested	L
Zambia	30-44	Men	6	45	45	general	tested	L
Zambia	45-59	Men	9	37	37	general	tested	L
Zambia	60-79	Men	8	20	20	general	tested	L
Zambia	15-29	Men	2	20	2	general	diagnosed	L
Zambia	30-44	Men	2	45	6	general	diagnosed	L
Zambia	45-59	Men	6	37	9	general	diagnosed	L
Zambia	60-79	Men	7	20	8	general	diagnosed	L
Zambia	15-29	Men	1	20	2	general	treated	L
Zambia	30-44	Men	2	45	2	general	treated	L
Zambia	45-59	Men	6	37	6	general	treated	L
Zambia	60-79	Men	6	20	7	general	treated	L
Zambia	15-29	Men	0	20	1	general	controlled	L
Zambia	30-44	Men	2	45	2	general	controlled	L
Zambia	45-59	Men	3	37	6	general	controlled	L
Zambia	60-79	Men	4	20	6	general	controlled	L
Zambia	all ages	Men	122	1614	1614	general	prevalence	L
Zambia	all ages	Men	25	1614	122	general	tested	L
Zambia	all ages	Men	17	1614	25	general	diagnosed	L
Zambia	all ages	Men	15	1614	17	general	treated	L
Zambia	all ages	Men	9	1614	15	general	controlled	L
